UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, ~~2021~~2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission File Number: 001-32240

(Exact name of registrant as specified in its charter)


Delaware						20-1308307
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

3460 Preston Ridge Road

Alpharetta

Georgia

30005

(Address of principal executive offices, including zip code)

(678) 566-6500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	NP	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

(Do not check if a smaller reporting company)

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May ~~3, 2021,~~2, 2022, there were ~~16,842,893~~16,788,143 shares of the Company’s Common Stock outstanding.

Table of Contents

TABLE OF CONTENTS


Part I — Financial Information

Item 1. Financial Statements			F-1

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			F-1718

Item 3. Quantitative and Qualitative Disclosure About Market Risk			F-25

Item 4. Controls and Procedures			F-25


Part II — Other Information

Item 1. Legal Proceedings			F-26

Item 1A. Risk Factors			F-26

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			F-26

Item 6. Exhibits			F-27

Table of Contents

Part I—FINANCIAL INFORMATION

Item 1. Financial Statements

NEENAH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except share and per share data)

(Unaudited)


		Three Months Ended March 31,				Three Months Ended March 31,
		2021		2020				2022		2021
Net sales		$	227.0	$	233.6
Net Sales							Net Sales	$	284.8	$	227.0
Cost of products sold	Cost of products sold	177.4		179.6			Cost of products sold	236.5		177.4
Gross profit		49.6		54.0
Gross Profit							Gross Profit	48.3		49.6
Selling, general and administrative expenses	Selling, general and administrative expenses	24.3		26.6			Selling, general and administrative expenses	30.3		24.3
Acquisition costs		12.0		1.0
Acquisition-related costs (Note 4)							Acquisition-related costs (Note 4)	5.3		12.0
Asset restructuring costs (Note 10)							Asset restructuring costs (Note 10)	0.6		—

COVID-19 costs	COVID-19 costs	0.5		1.1			COVID-19 costs	0.6		0.5
Other restructuring and non-routine costs		0		1.4

Other (income) expense - net		(0.8)		0.3
Operating income		13.6		23.6
Interest expense - net		3.1		2.9
Income before income taxes		10.5		20.7
Other income, net							Other income, net	(0.7)		(0.8)
Operating Income							Operating Income	12.2		13.6
Interest expense, net							Interest expense, net	5.0		3.1
Income Before Income Taxes							Income Before Income Taxes	7.2		10.5
Provision for income taxes	Provision for income taxes	2.2		4.3			Provision for income taxes	1.5		2.2

Net income		$	8.3	$	16.4
Net Income							Net Income	$	5.7	$	8.3

Earnings Per Common Share	Earnings Per Common Share						Earnings Per Common Share

Basic	Basic	$	0.49	$	0.97		Basic	$	0.34	$	0.49

Diluted	Diluted	$	0.49	$	0.97		Diluted	$	0.34	$	0.49

Weighted Average Common Shares Outstanding (in thousands)	Weighted Average Common Shares Outstanding (in thousands)						Weighted Average Common Shares Outstanding (in thousands)
Basic	Basic	16,835		16,817			Basic	16,808		16,835
Diluted	Diluted	16,873		16,850			Diluted	16,852		16,873

Cash Dividends Declared Per Share of Common Stock	Cash Dividends Declared Per Share of Common Stock	$	0.47	$	0.47		Cash Dividends Declared Per Share of Common Stock	$	0.475	$	0.47

See Notes to Condensed Consolidated Financial Statements

F-1

Table of Contents

NEENAH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In millions)

(Unaudited)

Three Months Ended March 31,
2021 2020
Net income $ 8.3 $ 16.4
Reclassification of amounts recognized in the condensed consolidated statements of operations:
Amortization of adjustments to pension and other postretirement benefit liabilities (Note 5) 1.7 1.6
Unrealized foreign currency loss (9.1) (4.0)
Loss from other comprehensive income items (7.4) (2.4)
Provision for income taxes 0 0.2
Other comprehensive loss (7.4) (2.6)
Comprehensive income $ 0.9 $ 13.8


	Three Months Ended March 31,
	2022		2021
Net Income	$	5.7	$	8.3
Reclassification of amounts recognized in the condensed consolidated statements of operations:
Amortization of adjustments to pension and other postretirement benefit liabilities (Note 6)	1.0		1.7


Unrealized foreign currency translation loss	(8.1)		(9.1)

Loss From Other Comprehensive Income Items	(7.1)		(7.4)
Provision for income taxes	—		—
Other Comprehensive Loss	(7.1)		(7.4)
Comprehensive Income (Loss)	$	(1.4)	$	0.9

See Notes to Condensed Consolidated Financial Statements

F-2

Table of Contents

NEENAH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions)

(Unaudited)


		March 31, 2021		December 31, 2020			March 31, 2022		December 31, 2021
ASSETS	ASSETS					ASSETS
Current Assets	Current Assets					Current Assets
Cash and cash equivalents	Cash and cash equivalents	$	41.0	$	37.1	Cash and cash equivalents	$	25.2	$	23.9

Accounts receivable (less allowances of $1.5 million and $1.5 million)		117.9		100.2
Inventories		115.1		108.9

Accounts receivable (less allowances of $1.8 million and $1.6 million)						Accounts receivable (less allowances of $1.8 million and $1.6 million)	165.1		142.3
Inventories (Note 3)						Inventories (Note 3)	148.3		138.5
Assets held for sale (Note 10)						Assets held for sale (Note 10)	10.5		10.5
Prepaid and other current assets	Prepaid and other current assets	25.0		25.1		Prepaid and other current assets	30.0		31.8
Total Current Assets	Total Current Assets	299.0		271.3		Total Current Assets	379.1		347.0
Property, Plant and Equipment	Property, Plant and Equipment					Property, Plant and Equipment
Property, plant and equipment, at cost	Property, plant and equipment, at cost	805.7		812.8		Property, plant and equipment, at cost	797.0		796.8
Less accumulated depreciation	Less accumulated depreciation	485.4		483.4		Less accumulated depreciation	505.5		501.3
Property, Plant and Equipment—net		320.3		329.4
Lease Right-of-Use Assets		19.9		20.2
Property, Plant and Equipment, net						Property, Plant and Equipment, net	291.5		295.5
Finance Lease Right-of-Use Assets						Finance Lease Right-of-Use Assets	20.2		20.8
Operating Lease Right-of-Use Assets						Operating Lease Right-of-Use Assets	17.6		17.8
Deferred Income Taxes	Deferred Income Taxes	20.6		18.3		Deferred Income Taxes	28.0		25.1
Goodwill	Goodwill	85.3		87.4		Goodwill	195.6		198.6
Intangible Assets—net		61.3		62.6
Intangible Assets, net						Intangible Assets, net	150.3		154.6
Over-funded Employee Benefit Plan (Note 6)						Over-funded Employee Benefit Plan (Note 6)	10.8		9.5
Other Noncurrent Assets	Other Noncurrent Assets	16.8		17.4		Other Noncurrent Assets	12.7		12.8
TOTAL ASSETS	TOTAL ASSETS	$	823.2	$	806.6	TOTAL ASSETS	$	1,105.8	$	1,081.7

LIABILITIES AND STOCKHOLDERS’ EQUITY	LIABILITIES AND STOCKHOLDERS’ EQUITY					LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities	Current Liabilities					Current Liabilities
Debt payable within one year (Note 4)		$	4.8	$	4.9
Lease liabilities payable within one year		3.3		3.2
Debt payable within one year (Note 5)						Debt payable within one year (Note 5)	$	5.7	$	6.4
Finance lease liabilities payable within one year						Finance lease liabilities payable within one year	0.8		0.8
Operating lease liabilities payable within one year						Operating lease liabilities payable within one year	3.3		3.3
Accounts payable	Accounts payable	72.4		46.0		Accounts payable	114.5		97.4
Liabilities of assets held for sale (Note 10)						Liabilities of assets held for sale (Note 10)	0.5		0.5
Accrued expenses	Accrued expenses	65.8		61.9		Accrued expenses	64.1		66.6
Total Current Liabilities	Total Current Liabilities	146.3		116.0		Total Current Liabilities	188.9		175.0
Long-term Debt (Note 4)		187.2		189.5
Noncurrent Lease Liabilities		18.0		18.4
Long-term Debt (Note 5)						Long-term Debt (Note 5)	456.7		434.9
Finance Lease Liabilities, Noncurrent						Finance Lease Liabilities, Noncurrent	19.9		20.4
Operating Lease Liabilities, Noncurrent						Operating Lease Liabilities, Noncurrent	15.7		15.9
Noncurrent Employee Benefits	Noncurrent Employee Benefits	92.5		96.8		Noncurrent Employee Benefits	75.9		77.7
Deferred Income Taxes	Deferred Income Taxes	11.8		12.3		Deferred Income Taxes	37.1		38.2
Other Noncurrent Obligations	Other Noncurrent Obligations	5.8		6.0		Other Noncurrent Obligations	3.8		3.6
TOTAL LIABILITIES	TOTAL LIABILITIES	461.6		439.0		TOTAL LIABILITIES	798.0		765.7
Contingencies and Legal Matters (Note 8)		0		0
Contingencies and Legal Matters (Note 9)						Contingencies and Legal Matters (Note 9)	—		—
TOTAL STOCKHOLDERS’ EQUITY	TOTAL STOCKHOLDERS’ EQUITY	361.6		367.6		TOTAL STOCKHOLDERS’ EQUITY	307.8		316.0
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	823.2	$	806.6	TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,105.8	$	1,081.7

See Notes to Condensed Consolidated Financial Statements

F-3

Table of Contents

NEENAH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(In millions, shares in thousands)

(Unaudited)


		2021 Activity														2022 Activity
		Common Stock														Common Stock
		Shares	Amount		Treasury Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total			Shares	Amount		Treasury Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total
Balance, December 31, 2020		18,746	$	0.2	$	(87.6)	$	338.3	$	220.4	$	(103.7)	$	367.6
Balance, December 31, 2021															Balance, December 31, 2021	18,819	$	0.2	$	(93.6)	$	342.9	$	163.4	$	(96.9)	$	316.0
Net income	Net income	—	—		—		—		8.3		—		8.3		Net income	—	—		—		—		5.7		—		5.7
Other comprehensive loss, including income taxes	Other comprehensive loss, including income taxes	—	—		—		—		—		(7.4)		(7.4)		Other comprehensive loss, including income taxes	—	—		—		—		—		(7.1)		(7.1)
Dividends declared	Dividends declared	—	—		—		—		(8.0)		—		(8.0)		Dividends declared	—	—		—		—		(8.2)		—		(8.2)

Stock options exercised	Stock options exercised	3	—		—		—		—		—		—		Stock options exercised	2	—		—		—		—		—		—
Restricted stock vesting (Note 7)	Restricted stock vesting (Note 7)	16	—		(0.4)		—		—		—		(0.4)		Restricted stock vesting (Note 7)	11	—		(0.2)		—		—		—		(0.2)
Stock-based compensation		—	—		—		1.5		—		—		1.5
Stock-based compensation (Note 7)															Stock-based compensation (Note 7)	—	—		—		1.6		—		—		1.6

Balance, March 31, 2021		18,765	$	0.2	$	(88.0)	$	339.8	$	220.7	$	(111.1)	$	361.6
Balance, March 31, 2022															Balance, March 31, 2022	18,832	$	0.2	$	(93.8)	$	344.5	$	160.9	$	(104.0)	$	307.8


		2020 Activity														2021 Activity
		Common Stock														Common Stock
		Shares	Amount		Treasury Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total			Shares	Amount		Treasury Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total
Balance, December 31, 2019		18,678	$	0.2	$	(82.8)	$	334.1	$	268.1	$	(113.3)	$	406.3
Balance, December 31, 2020															Balance, December 31, 2020	18,746	$	0.2	$	(87.6)	$	338.3	$	220.4	$	(103.7)	$	367.6
Net income	Net income	—	—		—		—		16.4		—		16.4		Net income	—	—		—		—		8.3		—		8.3
Other comprehensive loss, including income taxes	Other comprehensive loss, including income taxes	—	—		—		—		—		(2.6)		(2.6)		Other comprehensive loss, including income taxes	—	—		—		—		—		(7.4)		(7.4)
Dividends declared	Dividends declared	—	—		—		—		(8.0)		—		(8.0)		Dividends declared	—	—		—		—		(8.0)		—		(8.0)
Shares purchased (Note 7)		—	��		(3.6)		—		—		—		(3.6)

Stock options exercised	Stock options exercised	3	—		—		—		—		—		—		Stock options exercised	3	—		—		—		—		—		—
Restricted stock vesting (Note 7)	Restricted stock vesting (Note 7)	8	—		(0.2)		—		—		—		(0.2)		Restricted stock vesting (Note 7)	16	—		(0.4)		—		—		—		(0.4)
Stock-based compensation		—	—		—		1.5		—		—		1.5
Stock-based compensation (Note 7)															Stock-based compensation (Note 7)	—	—		—		1.5		—		—		1.5

Balance, March 31, 2020		18,689	$	0.2	$	(86.6)	$	335.6	$	276.5	$	(115.9)	$	409.8
Balance, March 31, 2021															Balance, March 31, 2021	18,765	$	0.2	$	(88.0)	$	339.8	$	220.7	$	(111.1)	$	361.6

See Notes to Condensed Consolidated Financial Statements

F-4

Table of Contents

NEENAH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

(Unaudited)

Three Months Ended March 31,
2021 2020
OPERATING ACTIVITIES
Net income $ 8.3 $ 16.4
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 8.6 8.6
Stock-based compensation 1.5 1.5
Deferred income tax provision (benefit) (2.4) 1.1
Unrealized loss on foreign currency forward contract (Note 1) 6.2 0
Provision for uncollectible accounts receivable 0 1.0
Decrease (Increase) in working capital 0.5 (13.7)
Pension and other postretirement benefits (2.0) (0.4)
Other 0 (0.3)
NET CASH PROVIDED BY OPERATING ACTIVITIES 20.7 14.2
INVESTING ACTIVITIES
Capital expenditures (4.8) (4.8)
Other (0.2) (0.1)
NET CASH USED IN INVESTING ACTIVITIES (5.0) (4.9)
FINANCING ACTIVITIES
Long-term borrowings (Note 4) 0.2 88.7
Repayments of long-term debt (Note 4) (1.4) (17.0)
Debt issuance costs (1.4) (0.5)
Cash dividends paid (8.0) (8.0)
Shares purchased (Note 7) (0.4) (3.8)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (11.0) 59.4
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS (0.8) (0.2)
NET INCREASE IN CASH AND CASH EQUIVALENTS 3.9 68.5
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 37.1 9.0
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 41.0 $ 77.5
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during period for interest, net of interest costs capitalized $ 2.6 $ 0.2
Cash paid during period for income taxes $ 1.5 $ 2.0
Non-cash investing activities:
Liability for equipment acquired $ 2.5 $ 2.4


	Three Months Ended March 31,
	2022		2021
OPERATING ACTIVITIES
Net Income	$	5.7	$	8.3
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10.6		8.6
Stock-based compensation	1.7		1.5
Deferred income tax benefit	(3.3)		(2.4)


Unrealized loss on foreign currency forward contracts (Note 1)	—		6.2




Decrease (increase) in working capital	(16.3)		0.5
Pension and other postretirement benefits	(0.8)		(2.0)

Other	0.4		—
Net Cash Provided by (Used In) Operating Activities	(2.0)		20.7

INVESTING ACTIVITIES
Capital expenditures	(8.3)		(4.8)


Other	(0.1)		(0.2)
Net Cash Used in Investing Activities	(8.4)		(5.0)

FINANCING ACTIVITIES
Long-term borrowings (Note 5)	41.2		0.2
Repayments of long-term debt (Note 5)	(20.6)		(1.4)
Debt issuance costs	—		(1.4)
Cash dividends paid	(8.0)		(8.0)
Shares purchased (Note 8)	(0.2)		(0.4)

Other	(0.2)		—
Net Cash Provided by (Used in) Financing Activities	12.2		(11.0)

Effect of Exchange Rate Changes on Cash and Cash Equivalents	(0.5)		(0.8)
Net Increase in Cash and Cash Equivalents	1.3		3.9
Cash and Cash Equivalents, Beginning of Year	23.9		37.1
Cash and Cash Equivalents, End of Period	$	25.2	$	41.0





SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during period for interest, net of interest costs capitalized	$	4.3	$	2.6
Cash paid during period for income taxes	$	4.3	$	1.5
Non-cash investing activities:
Liability for equipment acquired	$	4.3	$	2.5

See Notes to Condensed Consolidated Financial Statements

F-5

Table of Contents

NEENAH, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in millions, except as noted)

Note 1. Background and Basis of Presentation

Background

Neenah, Inc. ("Neenah" or the "Company"), is a Delaware corporation incorporated in April 2004. The Company has 2 primary operations: its ~~technical products~~Technical Products business and its ~~fine paper~~Fine Paper and ~~packaging~~Packaging business. See Note 9,11, "Business Segment Information."

Basis of Consolidation and Presentation

These statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") and, in accordance with those rules and regulations, do not include all information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). Management believes that the disclosures made are adequate for a fair presentation of the Company’s results of operations, financial position and cash flows. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the results of operations, financial position and cash flows for the interim periods presented herein. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make extensive use of estimates and assumptions that affect the reported amounts and disclosures. Actual results may vary from these estimates.

These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s most recent Annual Report on Form 10-K. The results of operations for any interim period are not necessarily indicative of the results of operations to be expected for the full year.

The condensed consolidated financial statements of Neenah and its subsidiaries included herein are unaudited. The condensed consolidated financial statements include the financial statements of the Company and its wholly owned and majority owned subsidiaries. Intercompany balances and transactions have been eliminated.

~~Impacts of COVID-19~~

The Company continues to assess the impacts of the novel coronavirus pandemic (“COVID-19” or the "pandemic") on its various accounting estimates and significant judgments, including those that require consideration of forecasted financial information in the context of the unknown future impacts of COVID-19, using information that is reasonably available at this time. The accounting estimates and other matters assessed included, but were not limited to, goodwill, indefinite-lived intangibles and other long-lived assets, allowance for uncollectible accounts receivable, valuation allowances for tax assets and allowances for sales discounts and returns. During the three months ended March 31, 2021, the Company qualitatively reviewed its fixed assets and intangibles including goodwill and indefinite-lived intangibles and noted no impairment indicators were triggered.

The Company recorded incremental and direct costs of responding to COVID-19 of $0.5 million for the three months ended March 31, 2021. For the three months ended March 31, 2020, the Company accrued for a one-time special payment to its mill operators of $1.1 million related to COVID-19.

~~F-6~~

~~Table of Contents~~

Earnings per Share ("EPS")

The following table presents the computation of basic and diluted EPS (dollars in millions except per share amounts, shares in thousands):

Earnings Per Basic Common Share


		Three Months Ended March 31,				Three Months Ended March 31,
		2021		2020				2022		2021
Income from continuing operations	Income from continuing operations	$	8.3	$	16.4		Income from continuing operations	$	5.7	$	8.3
Amounts attributable to participating securities	Amounts attributable to participating securities	0		(0.1)			Amounts attributable to participating securities	—		—

Net income available to common stockholders	Net income available to common stockholders	$	8.3	$	16.3		Net income available to common stockholders	$	5.7	$	8.3

Weighted-average basic shares outstanding	Weighted-average basic shares outstanding	16,835		16,817			Weighted-average basic shares outstanding	16,808		16,835


Basic earnings per share	Basic earnings per share	$	0.49	$	0.97		Basic earnings per share	$	0.34	$	0.49

F-6

Table of Contents

Earnings Per Diluted Common Share


		Three Months Ended March 31,				Three Months Ended March 31,
		2021		2020				2022		2021
Income from continuing operations	Income from continuing operations	$	8.3	$	16.4		Income from continuing operations	$	5.7	$	8.3
Amounts attributable to participating securities	Amounts attributable to participating securities	(0.1)		(0.1)			Amounts attributable to participating securities	(0.1)		(0.1)

Net income available to common stockholders	Net income available to common stockholders	$	8.2	$	16.3		Net income available to common stockholders	$	5.6	$	8.2

Weighted-average basic shares outstanding	Weighted-average basic shares outstanding	16,835		16,817			Weighted-average basic shares outstanding	16,808		16,835
Add: Assumed incremental shares under stock compensation plans (a)	Add: Assumed incremental shares under stock compensation plans (a)	38		33			Add: Assumed incremental shares under stock compensation plans (a)	44		38
Weighted-average diluted shares	Weighted-average diluted shares	16,873		16,850			Weighted-average diluted shares	16,852		16,873


Diluted earnings per share	Diluted earnings per share	$	0.49	$	0.97		Diluted earnings per share	$	0.34	$	0.49

(a) For the three months ended March 31, ~~2021~~2022 and ~~2020,~~2021, there were ~~324,197~~343,000 and ~~267,152~~324,000 potentially dilutive options, respectively, excluded from the computation of dilutive common shares because the exercise price of such options exceeded the average market price of the Company’s Common Stock.

Fair Value of Financial Instruments

The Company measures the fair value of financial instruments in accordance with Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC Topic 820") which establishes a framework for measuring fair value. ASC Topic 820 provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

As of March 31, ~~2021,~~2022, the carrying values of the Company’s debt approximated fair value. The fair value for all debt instruments was estimated from Level 2 measurements using rates currently available to the Company for debt of the same remaining maturities.

During the three months ended March 31, 2021, in anticipation of the ~~ITASA~~Itasa acquisition (as further defined and discussed in Note ~~10, "Subsequent Events"~~4, "Acquisition"), the Company entered into foreign currency forward contracts to purchase €205.9 million at a weighted average exchange rate of $1.203 per euro on April 6, 2021. These contracts were designed to act as economic hedges for the ~~pending ITASA~~Itasa acquisition and were marked to market at an unrealized loss of $6.2 million ~~which was recorded in the "Acquisition costs" on the Condensed Consolidated Statement of Operations and reflected in "Accrued expenses" on the Condensed Consolidated Balance Sheet as of~~at March 31, 2021. The Company settled these contracts on April 6, 2021 for a realized loss of $5.1 million.

~~F-7~~

~~Table of Contents~~

As of March 31, ~~2021,~~2022, the Company had ~~$4.3~~$0.6 million in marketable securities in the U.S. classified as "Other Noncurrent Assets" on the Condensed Consolidated Balance Sheet. The cost of such marketable securities was ~~$4.6~~$0.6 million. Fair value for the Company’s marketable securities was estimated from Level 1 inputs. The Company’s U.S. marketable securities are designated for the payment of benefits under its supplemental employee retirement plan ("SERP"). As of March 31, ~~2021,~~2022, Neenah Germany had investments of ~~$2.5~~$2.4 million that were restricted to the payment of certain post-retirement employee benefits of which ~~$0.8~~$0.7 million and $1.7 million are classified as "Prepaid and other current assets" and "Other Noncurrent Assets", respectively, on the Condensed Consolidated Balance Sheet. The cost of these investments approximated market.

Revenue from Contracts with Customers

The Company recognizes sales revenue at a point in time following the transfer of control of the product to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. Sales are reported net of allowable discounts and estimated returns. Reserves for cash discounts, trade allowances and sales returns are estimated using historical experience. The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill our promise to transfer the associated products. Accordingly, the Company records customer payments of shipping and handling costs as a component of net sales and classifies such costs as a component of cost of sales. The Company excludes tax amounts assessed by governmental authorities that are both (i) imposed on and concurrent with a specific revenue-producing transaction and (ii) collected from customers from our measurement of transaction prices. Accordingly, such tax amounts are not included as a component of net sales or cost of sales.

F-7

Table of Contents

The Company considers each transaction/shipment as a separate performance obligation. Neenah recognizes revenue when the title transfers to the customer. As such, the remaining performance obligations at period end are not considered significant.

Refer to Note 9,11, "Business Segment Information" for disaggregation of segment revenue from contracts with customers for the three months ended March 31, ~~2021~~2022 and ~~2020.~~

~~Allowance for Uncollectible Accounts Receivable~~

Losses on receivables are estimated based on known troubled accounts and historical experience of losses incurred. Receivables are considered impaired and written-off when it is expected that contractual payments due will not be collected in accordance with the terms of the agreement. The allowance for uncollectible accounts receivable was $1.5 million and $1.5 million as of March 31, 2021 and December 31, 2020, respectively. The Company recorded a $1.0 million provision for uncollectible accounts receivable from the impacts of COVID-19 for the three months ended March 31, 2020. There were no significant adjustments for the three months ended March 31, 2021.

~~Leases~~

The Company has operating leases for corporate offices, warehouses, converting operations, and certain equipment, with remaining lease terms of up to 10 years, some of which include options to extend the leases for up to five years. The Company determines if an arrangement is a lease at inception. Operating leases with terms greater than 12 months are included in "Lease Right-of-Use Assets", "Lease liabilities payable within one year" and "Noncurrent Lease Liabilities" on the Condensed Consolidated Balance Sheets. As of March 31, 2021, the Company did not have any material financing leases.

Note 2. Accounting Standards Changes

As of March 31, ~~2021,~~2022, there were no amendments to the ASC that will have or are reasonably likely to have a material effect on the Company’s financial position, results of operations or cash flows upon adoption.

~~F-8~~

~~Table of Contents~~

Note 3. Supplemental Balance Sheet Data

The following table presents inventories by major class:


		March 31, 2021		December 31, 2020			March 31, 2022		December 31, 2021
Raw materials	Raw materials	$	30.2	$	28.9	Raw materials	$	52.0	$	54.7
Work in progress	Work in progress	24.6		20.1		Work in progress	43.2		32.6
Finished goods	Finished goods	63.3		61.0		Finished goods	67.2		64.0
Supplies and other	Supplies and other	4.5		5.3		Supplies and other	4.4		3.8
		122.6		115.3			166.8		155.1
Adjust FIFO inventories to LIFO cost		(7.5)		(6.4)
Excess of FIFO over LIFO cost						Excess of FIFO over LIFO cost	(18.5)		(16.6)
Total	Total	$	115.1	$	108.9	Total	$	148.3	$	138.5

The ~~FIFO~~first-in, first-out ("FIFO") values of inventories valued on the ~~LIFO~~last-in, first-out ("LIFO") method were ~~$96.2~~$104.3 million and ~~$88.5~~$95.4 million as of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively. ~~For the three months ended March 31, 2021, income from continuing operations before income taxes was reduced by less than $0.1 million due to a decrease in certain LIFO inventory quantities.~~

The following table presents changes in accumulated other comprehensive income (loss) ("AOCI") for the three months ended March 31, ~~2021:~~2022:


		Net Unrealized Foreign Currency Translation Loss		Net Loss from Pension and Other Postretirement Liabilities		Accumulated Other Comprehensive Loss			Net Unrealized Foreign Currency Translation Loss		Net Loss from Pension and Other Postretirement Liabilities		Accumulated Other Comprehensive Loss
AOCI — December 31, 2020		$	(1.7)	$	(102.0)	$	(103.7)
Other comprehensive loss before reclassifications		(9.1)		0		(9.1)
AOCI — December 31, 2021								AOCI — December 31, 2021	$	(25.2)	$	(71.7)	$	(96.9)
Other comprehensive income (loss) before reclassifications								Other comprehensive income (loss) before reclassifications	(8.1)		—		(8.1)
Amounts reclassified from AOCI	Amounts reclassified from AOCI	0		1.7		1.7		Amounts reclassified from AOCI	—		1.0		1.0
Income (loss) from other comprehensive income items	Income (loss) from other comprehensive income items	(9.1)		1.7		(7.4)		Income (loss) from other comprehensive income items	(8.1)		1.0		(7.1)
Provision (benefit) for income taxes	Provision (benefit) for income taxes	(0.4)		0.4		0		Provision (benefit) for income taxes	(0.3)		0.3		—
Other comprehensive income (loss)	Other comprehensive income (loss)	(8.7)		1.3		(7.4)		Other comprehensive income (loss)	(7.8)		0.7		(7.1)
AOCI — March 31, 2021		$	(10.4)	$	(100.7)	$	(111.1)
AOCI — March 31, 2022								AOCI — March 31, 2022	$	(33.0)	$	(71.0)	$	(104.0)

For the three months ended March 31, ~~2021~~2022 and ~~2020,~~2021, the Company reclassified ~~$1.7~~$1.0 million and ~~$1.6~~$1.7 million of costs, respectively, from AOCI to "Other ~~expense -~~income, net" on the Condensed Consolidated Statements of Operations. For the three months ended March 31, ~~2021~~2022 and ~~2020,~~2021, the Company recognized an income tax benefit of ~~$0.4~~$0.3 million and ~~$0.5~~$0.4 million, respectively, related to such reclassifications classified as "Provision for income taxes" on the Condensed Consolidated Statements of Operations.

F-8

Table of Contents

Note 4. ~~Debt~~Acquisition

~~Long-term debt consisted~~Acquisition of Itasa

On April 6, 2021, the Company completed the acquisition (the “Acquisition”) of all of the ~~following:~~

March 31, 2021 December 31, 2020
2020 Term Loan B (variable rates) due June 2027 $ 198.5 $ 199.0
Global Revolving Credit Facility (variable rates) due December 2023 0 0
German loan agreement (2.45% fixed rate) due in quarterly installments ending September 2022 2.0 2.4
German loan agreement (1.45% fixed rate) due in quarterly installments ending September 2022 2.1 2.6
Debt discounts and deferred financing costs (10.6) (9.6)
Total debt 192.0 194.4
Less: Debt payable within one year 4.8 4.9
Long-term debt $ 187.2 $ 189.5
outstanding capital stock of Global Release Liners, S.L., a Spanish limited company (“Itasa”), from Magnum Capital and other minority shareholders for $240.2 million in cash, net of cash on hand and debt extinguishment, and including a loss on foreign currency forward contracts. Itasa, through its subsidiaries, is a leading global coater and converter of release liners used in hygiene, tapes, industrial, labels, composites and various other end markets. The Acquisition was funded with available cash-on-hand and the net proceeds of the Term Loan B discussed in Note 5, "Debt." In 2021, the Company incurred $12.8 million of costs related to the Acquisition, including a realized loss of $5.1 million related to the foreign currency forward contracts negotiated to fund the purchase price in euros. See Note 1, "Background and Basis of Presentation," for further discussion on these contracts. The Itasa business is part of the Company's Technical Products segment.

The Company accounted for the transaction using the acquisition method in accordance with ASC Topic 805, Business Combinations ("ASC Topic 805"). The following table summarizes the final allocation of the purchase price to the fair value of the assets acquired and liabilities assumed as of April 6, 2021:


Assets Acquired
Cash and cash equivalents	$	34.0
Accounts receivable	20.7
Inventories	24.6
Prepaid and other current assets	2.1
Property, plant and equipment	19.8
Finance lease Right-of-Use assets	22.1
Operating lease Right-of-Use assets	0.1

Non-amortizable intangible assets	4.1
Amortizable intangible assets	100.5
Other assets	0.3
Goodwill	119.5
Total assets acquired	347.8

Liabilities Assumed
Accounts payable	22.3
Accrued expenses	6.5
Long-term debt	26.4
Lease liabilities - Finance	22.1
Lease liabilities - Operating	0.1
Deferred income taxes	27.5
Other noncurrent obligations	0.3
Total liabilities assumed	105.2

Net assets acquired	$	242.6

The Company estimated the fair value of the assets and liabilities acquired in accordance with ASC Topic 820, Fair Value Measurements and Disclosures ("ASC Topic 820"). The fair value of amortizable and non-amortizable intangible assets was determined by applying a royalty rate to projected revenue, net of tax impacts and adjusted for present value considerations. The Company determined the fair value of acquired property, plant and equipment using a combination of cost and market approaches. In general, the fair value of other acquired assets and liabilities was determined using the cost basis of Itasa. There were no material changes to the final purchase price allocation during the three months ended March 31, 2022.

F-9

Table of Contents

The excess of the purchase price over the fair value of the tangible net assets and identifiable intangible assets acquired was recorded as goodwill. The factors contributing to the amount of goodwill recognized are based on several strategic and synergistic benefits that are expected to be realized from the acquisition of Itasa. These benefits include entry into profitable new markets for silicone release liners with new capabilities and recognized brands and synergies from combining the business with Neenah's existing infrastructure. None of the goodwill recognized as part of the Itasa acquisition will be deductible for income tax purposes. All of the acquired goodwill was allocated to the Technical Products segment.

Note 5. Debt

Long-term debt consisted of the following:


	March 31, 2022		December 31, 2021
Term Loan B Credit Facility (variable rates) due April 2028	$	446.6	$	447.8
Global Revolving Credit Facility (variable rates) due December 2023	23.3		0.9
Second German loan agreement (2.45% fixed rate) due in quarterly installments ending September 2022	0.6		1.0
Third German loan agreement (1.45% fixed rate) due in quarterly installments ending September 2022	0.6		0.9
Deferred financing costs	(8.7)		(9.3)
Total debt	462.4		441.3
Less: Debt payable within one year	5.7		6.4
Long-term debt	$	456.7	$	434.9

Term Loan B Credit Facility

On June 30, 2020, the Company entered into a Term Loan Credit Agreement (the “2020 Term Loan Credit Agreement”) which provides a seven-year Term Loan B credit facility (the "Term B Facility") in the initial principal amount of $200 million (the "2020 Term Loan B".) The 2020 Term Loan B was executed in a single $200 million draw on the closing date. Proceeds under the Term B Facility were used to redeem in full $175 million of senior unsecured notes due May 2021, repay borrowings under the Company’s senior secured revolving credit facility, pay fees and expenses of the transaction and for general corporate purposes. As of March 31, 2021, the weighted-average interest rate on outstanding 2020 Term Loan B borrowings was 5.0% per annum. The 2020 Term Loan B was repayable in equal quarterly installments in an aggregate annual amount equal to 1% of the original principal amount of the Term B Facility (subject to certain reductions in connection with debt prepayments and debt buybacks). As of March 31, 2021, the Company was in compliance with all terms of the 2020 Term Loan Credit Agreement.

On April 6, 2021, in connection with the acquisition of ~~ITASA,~~Itasa, the Company entered into an Amendment and Restatement Agreement (the "Term Loan Credit Agreement"), which provides a seven-year term loan B facility (the "Term B Facility") in the initial principal amount of $450 million (the “Term Loan B”)~~, which replaces the 2020~~. The Term Loan ~~B. See Note 10, "Subsequent Events"~~B is repayable in equal quarterly installments in an aggregate annual amount equal to 1% of the original principal amount of the Term Loan B (subject to certain reductions in connection with debt prepayments and debt buybacks). The entire unpaid principal balance of the Term Loan B will be due and payable at maturity on April 6, 2028. Cash proceeds of borrowings on the closing date under the Term Loan B were used by the Company to pay cash consideration for the Itasa Acquisition, including the repayment of certain existing debt of Itasa, and to pay fees and expenses in connection with the Itasa Acquisition, the Term Loan B and the contemporaneous amendment of the Global Revolving Credit Facility to permit the Itasa Acquisition.

Under the terms of the Term Loan Credit Agreement, borrowings under the Term B Facility will bear interest, as selected by the Company, at a per annum rate equal to either (a) the reserve-adjusted LIBOR rate for interest periods of one or three months, plus an applicable rate of 3.0% per annum, or (b) the Alternate Base Rate (as defined in the Term B Credit Agreement), plus an applicable rate of 2.0% per annum. The Alternate Base Rate is subject to a “floor” of 1.5%, and the adjusted LIBOR rate is subject to a “floor” of 0.5%. As of March 31, 2022, the weighted-average interest rate on outstanding Term Loan borrowings was 3.5% per annum. The Term Loan Credit Agreement includes customary LIBOR replacement language, including, but not limited to, the use of rates based on the secured overnight financing rate (“SOFR”) recommended by the Alternative Reference Rates Committee, a steering committee comprised of U.S. financial market participants, as a replacement rate for ~~further discussion.~~LIBOR. SOFR is a broad measure of the cost of borrowing cash in the overnight U.S. Treasury repo market, and is administered by the Federal Reserve Bank of New York.

The Term Loan Credit Agreement contains covenants with which the Company and its subsidiaries must comply during the term of the agreement, which the Company believes are ordinary and standard for agreements of this nature.

Secured Revolving Credit Facility

In December 2018, the Company amended its existing global secured revolving credit facility (the “Global Revolving Credit Facility”) by entering into a Fourth Amended and Restated Credit Agreement, dated December 10, 2018 (the “ABL Credit Agreement”). The Global Revolving Credit Facility will mature on December 10, 2023.

~~On June 30, 2020, the Company amended the ABL Credit Agreement to among other things, (a) remove the applicable components~~

F-10

Table of the TLB Priority Collateral from the borrowing base calculation under the Global Revolving Credit Facility, (b) permit the pledging of the Collateral under the Term B Facility and subordinate liens of the ABL Credit Agreement lenders on TLB Priority Collateral to the first position liens on TLB Priority Collateral under the Term B Facility, (c) reduce the U.S. revolving credit facility amount from $150 million to $125 million, (d) reduce the German revolving credit facility amount from $75 million to $50 million, and (e) adjust certain reporting and financial covenant activation and deactivation thresholds.Contents

On April 6, 2021, in connection with the acquisition of ~~ITASA,~~Itasa, the Company amended the ABL Credit Agreement by entering into a Fourth Amendment to Fourth Amended and Restated Credit Agreement (the "Fourth Amendment"). The Fourth Amendment, among other things, adds provisions (a) specifically permitting the consummation of the Acquisition, (b) permitting the incurrence of the Term Loan B, and (c) permitting certain indebtedness, liens and other transactions to facilitate consummation of the Acquisition and the financing of working capital for Itasa.

On November 16, 2021, the Company further amended the ABL Credit Agreement by entering into a Fifth Amendment to the Fourth Amended and Restated Credit Agreement (the “Fifth Amendment”). The Fifth Amendment modified certain provisions of the ABL Credit Agreement to address the discontinuation of LIBOR published rates for Euro and Sterling denominated borrowings on December 31, 2021 and the planned discontinuation of LIBOR published rates for United States Dollar denominated borrowings after June 30, 2023. The Fifth Amendment provides customary LIBOR replacement language, including, among other things, (i) rules on determination of the replacement reference interest rates upon occurrence of specific events, (ii) the mechanics of how applicable interest rates will be determined in each case, (iii) the applicable fallback reference interest rates in case determination fails or rate ceases to be determinable. For loans not denominated in United States dollars, the Fifth Amendment provided that from the effective date of such amendment, (a) Euro-denominated loans under the Global Revolving Credit Facility would bear interest based on (1) the Euro short-term rate for German swingline borrowings, and (2) the Euro interbank offered rate for loans under the German Revolving Credit Facility other than swingline borrowings, for interest periods of one or three months, and (b) Sterling-denominated loans would bear interest based upon the Sterling overnight index average (“SONIA”). There were no Euro or Sterling-denominated loans outstanding under the Global Revolving Credit Facility as ~~further discussed in Note 10, "Subsequent Events".~~of March 31, 2022. For United States dollar-denominated loans under the Global Revolving Credit Facility, the LIBOR replacement language includes, without limitation, the use of rates based on SOFR as a replacement rate for LIBOR.

Availability under the Global Revolving Credit Facility varies over time depending on the value of the Company’s inventory, receivables and various capital assets. As of March 31, ~~2021,~~2022, the Company had 0$23.3 million borrowings and $0.3 million in letters of credit outstanding under the Global Revolving Credit Facility and ~~$155.7~~$137.8 million of available credit (based on exchange rates at March 31, ~~2021)~~2022). As of ~~December~~March 31, ~~2020,~~2022, the weighted-average interest rate under the Global Revolving Credit Facility was ~~1.3 percent~~2.4% per annum.

The ABL Credit Agreement contains covenants with which the Company and its subsidiaries must comply during the term of the agreement, which the Company believes are ordinary and standard for agreements of this nature. ~~As of March 31, 2021, the Company was in compliance with all terms of the ABL Credit Agreement.~~

Under the terms of the Term Loan Credit Agreement and the ABL Credit Agreement, the Company has limitations on its ability to repurchase shares of and pay dividends on its Common Stock. These limitations are triggered depending on the Company’s credit availability under the ABL Credit Agreement and leverage levels under the Term Loan Credit Agreement. As of March 31, ~~2021,~~2022, none of these covenants were restrictive to the Company’s ability to repurchase shares of and pay dividends on its Common Stock.

~~For additional information about the Company's debt agreements, see Note 6, "Debt" of the Notes to Consolidated Financial Statements in the 2020 Form 10-K.~~

~~F-10~~

~~Table of Contents~~

Note 5.6. Pension and Other Postretirement Benefits

Pension Plans

Substantially all active employees of the Company’s U.S. operations participate in defined benefit pension plans and/or defined contribution retirement plans. The Company has defined benefit plans for substantially all its employees in Germany and the United Kingdom. In addition, the Company maintains a SERP, which is a non-qualified defined benefit plan, and a supplemental retirement contribution plan (the "SRCP"), which is a non-qualified, unfunded defined contribution plan. The Company provides benefits under the non-qualified SERP and SRCP plans to the extent necessary to fulfill the intent of its retirement plans without regard to the limitations set by the Internal Revenue Code on qualified retirement benefit plans.

F-11

Table of Contents

The following table presents the components of net periodic benefit cost for the Company’s defined benefit plans and postretirement plans other than pensions:

Components of Net Periodic Benefit Cost for Defined Benefit Plans


		Pension Benefits				Postretirement Benefits Other than Pensions					Pension Benefits				Postretirement Benefits Other than Pensions
		Three Months Ended March 31,									Three Months Ended March 31,
		2021		2020		2021		2020			2022		2021		2022		2021
Service cost	Service cost	$	1.1	$	1.2	$	0.3	$	0.3	Service cost	$	0.9	$	1.1	$	0.2	$	0.3
Interest cost	Interest cost	3.0		3.5		0.1		0.2		Interest cost	2.7		3.0		0.2		0.1
Expected return on plan assets (a)	Expected return on plan assets (a)	(4.9)		(5.2)		0		0		Expected return on plan assets (a)	(4.2)		(4.9)		—		—
Recognized net actuarial loss	Recognized net actuarial loss	1.4		1.3		0.2		0.2		Recognized net actuarial loss	0.8		1.4		0.2		0.2
Amortization of prior service benefit	Amortization of prior service benefit	0.1		0.1		0		0		Amortization of prior service benefit	—		0.1		—		—

Net periodic benefit cost	Net periodic benefit cost	$	0.7	$	0.9	$	0.6	$	0.7	Net periodic benefit cost	$	0.2	$	0.7	$	0.6	$	0.6

(a) The expected return on plan assets is determined by multiplying the fair value of plan assets at the prior year-end (adjusted for estimated current year cash benefit payments and contributions) by the expected long-term rate of return. The Dutch pension plan is funded through an insurance contract, and the expected return on plan assets is calculated based on the discount rate of the insured obligations.

The Company records the service cost component of net periodic benefit cost as part of cost of sales and selling, general and administrative ("SG&A") expenses; and the non-service cost components of net periodic benefit cost (i.e., interest cost, expected return on plan assets, net actuarial gains or losses, and amortization of prior service cost or credits) as part of "Other ~~expense -~~income, net" on the Condensed Consolidated Statements of Operations.

For the three months ended March 31, ~~2021,~~2022, the Company made ~~$2.7~~$1.9 million of aggregate contributions to qualified and nonqualified defined benefit pension trusts and payments toof pension benefits for unfunded pension and other ~~postretirement~~post-employment benefit plans. The Company expects to make ~~$11.8~~$10.0 million of such payments in calendar ~~2021.~~2022. The Company made similar payments of ~~$1.8~~$2.7 million and $11.5 million for the three months ended March 31, ~~2020~~2021 and for the year ended December 31, ~~2020,~~2021, respectively.

Note 6.7. Stock Compensation Plan

Stock Options and Stock Appreciation Rights ("Options")

There were 0no Options awarded ~~during the three months ended March 31, 2021.~~

~~The following table presents information regarding Options that~~or vested during the three months ended March 31, ~~2021:~~


~~Options vested~~	~~15,869~~
~~Aggregate grant date fair value of Options vested (in millions)~~	$	~~0.2~~

~~F-11~~

~~Table of Contents~~

2022.

The following table presents information regarding outstanding Options:


		March 31, 2021		December 31, 2020			March 31, 2022		December 31, 2021
Options outstanding	Options outstanding	376,354		380,844		Options outstanding	357,963		361,431
Aggregate intrinsic value (in millions)	Aggregate intrinsic value (in millions)	$	0.8	$	1.2	Aggregate intrinsic value (in millions)	$	0.1	$	0.4
Per share weighted average exercise price	Per share weighted average exercise price	$	71.47	$	70.99	Per share weighted average exercise price	$	73.23	$	72.76
Exercisable Options	Exercisable Options	375,339		362,651		Exercisable Options	357,205		359,543
Aggregate intrinsic value (in millions)	Aggregate intrinsic value (in millions)	$	0.8	$	1.2	Aggregate intrinsic value (in millions)	$	0.1	$	0.4
Unvested Options	Unvested Options	1,015		18,193		Unvested Options	758		1,888
Per share weighted average grant date fair value	Per share weighted average grant date fair value	$	10.32	$	14.48	Per share weighted average grant date fair value	$	10.32	$	10.32

F-12

Table of Contents

Performance Share Units ("PSUs") and Restricted Share Units ("RSUs")

For the three months ended March 31, ~~2021,~~2022, the Company granted target awards of ~~86,020~~105,126 PSUs. The measurement period for the PSUs is January 1, ~~2021~~2022 through December 31, ~~2023. The PSUs vest on the third anniversary from the date of grant.~~2024. Common Stock ~~of an amount between 0 and~~equal to not more than 200 percent of the PSUs target will be awarded based on the Company’s return on invested capital, consolidated revenue growth and free cash flow as a percentage of net ~~sales, and~~sales. The Company's total return to shareholders relative to the companies in the Russell 2000® Value small cap ~~index.~~index is a modifier in the calculation. The Company’s return on invested capital, consolidated revenue growth and free cash flow ~~as a percentage of net sales~~ are adjusted for certain items as further described in the Performance Share Unit Award Agreement. The average price on the dates of grant for the PSUs was ~~$54.34~~$45.96 per share.

For the three months ended March 31, ~~2021,~~2022, the Company awarded ~~39,521~~50,316 RSUs to ~~certain~~ employees. The ~~weighted average~~weighted-average grant date fair value of such awards was ~~$53.06~~$45.95 per share and ~~one third of the shares will~~ vest ~~on each of the first~~in equal amounts per year for three ~~anniversaries of~~years on the grant date anniversary, with certain exceptions for retiring employees. During the vesting period, the holders of the RSUs are entitled to dividends, but the RSUs do not have voting ~~rights.~~rights and are forfeited in the event the holder is no longer an employee on the vesting date, as further described in the Restricted Stock Unit Award Agreement.

Generally, the RSUs and PSUs are forfeited in the event the holder is no longer working for the Company on the vesting date. However, under specific circumstances, vesting may be accelerated or reflect pro-rata vesting.

Note 7.8. Stockholders' Equity

Common Stock

As of March 31, ~~2021~~2022 and December 31, ~~2020,~~2021, the Company had ~~16,841,000~~16,788,000 shares and ~~16,829,000~~16,779,000 shares of Common Stock outstanding, respectively.

In November 2020, the Company's Board of Directors authorized an evergreen program for the purchase of up to $25 million of outstanding Common Stock effective January 1, 2021 (the "Stock Purchase Plan"). The program does not require the Company to purchase any specific number of shares and may be suspended or discontinued at any time. Purchases under the Stock Purchase Plan will be made from time to time in the open market or in privately negotiated transactions in accordance with the requirements of applicable law. The timing and amount of any purchases will depend on share price, market conditions and other factors. ~~The Company also had $25 million repurchase programs in place during~~For the ~~preceding two years that expired in December 2020 (the “2020 Stock Purchase Plan”) and December 2019 (the “2019 Stock Purchase Plan”), respectively.~~

~~The following table shows~~three months ended March 31, 2022, there were no shares ~~purchased and value ($ in millions)~~repurchased under ~~the respective stock purchase plans:~~

Three Months Ended March 31,
2021 2020
Shares Amount Shares Amount
Stock Purchase Plan 0 $ 0 0 $ 0
2020 Stock Purchase Plan 0 0 59,577 3.6
this program.

For the three months ended March 31, ~~2021~~2022 and ~~2020,~~2021, the Company acquired ~~6,881~~an additional 4,671 and ~~3,476~~6,881 shares of Common Stock, respectively, at a cost of ~~$0.4~~$0.2 million and ~~$0.2~~$0.4 million, respectively for shares surrendered by employees to pay taxes due on vested restricted stock awards.

~~F-12~~

Note 8.9. Contingencies and Legal Matters

Litigation

The Company is involved in certain legal actions and claims arising in the ordinary course of business. While the outcome of these legal actions and claims cannot be predicted with certainty, it is the opinion of management that the outcome of any such claim which is pending or threatened, either individually or on a combined basis, will not have a material effect on the consolidated financial condition, results of operations or cash flows of the Company.

Income Taxes

The Company periodically undergoes examination by the IRS, as well as various state and foreign jurisdictions. These tax authorities routinely challenge certain deductions and credits reported by the Company on its income tax returns. No significant tax audit findings are being contested at this time with either the IRS or any state or foreign tax authority.

Employees and Labor Relations

The Company’s U.S. union employees are represented by the USW. Approximately 50 percent of salaried employees and 80 percent of hourly employees of Neenah Germany are eligible to be represented by the Mining, Chemicals and Energy Trade Union, Industriegewerkschaft Bergbau, Chemie and Energie (the "IG BCE"). In Spain and Mexico, most of our employees are eligible to be represented by the local workers' unions: Confederacion Sindical de Comisiones Obreras ("CCOO") and Langile Abertzaalen Batzordeak ("LAB") in Spain; and Federacion de Trabajadores del Estado de Queretaro ("CTM") in Mexico. In the Netherlands, most of our employees are eligible to be represented by the Christelijke Nationale Vakbond ("CNV") and the

F-13

Table of Contents

Federatie Nederlandse Vakvereniging ("FNV"). As of March 31, ~~2021,~~2022, the Company had ~~275~~690 U.S. employees covered under collective bargaining agreements that will expire in the next 12 months.

The following table shows the expiration dates of the Company’s various bargaining agreements and the number of employees covered under each of these agreements:


Contract Expiration Date	Location	Union	Number of Employees
~~April 2021~~	~~Eerbeek, Netherlands~~	~~CNV, FNV~~	~~(a)~~
November 2021 (b)	Lowville, NY	USW	8884
December 2021 (b)	Andoain, Spain	CCOO, LAB	(a)
January 2022 (b)	Whiting, WI	USW	~~187~~
~~May 2022~~	~~Appleton, WI~~	~~USW~~	85192
June 2022	Neenah, WI	USW	~~179~~213
July 2022	Munising, MI	USW	~~178~~201
September 2022	~~Neenah~~Weidach and Bruckmuhl, Germany	IG BCE	(a)
April 2023	Eerbeek, Netherlands	CNV, FNV	(a)
(c)	Queretaro, Mexico	CTM	(a)

(a) Under ~~German and Dutch~~the local laws, union membership is voluntary and does not need to be disclosed to the Company. As a result, the number of employees covered by the collective bargaining agreement with the CCOO, LAB, IG BCE, CNV, FNV and ~~the CNV and FNV~~CTM cannot be determined.

(b) The Company is currently in negotiations with the ~~CNV and FNV.~~respective unions. Until new contracts are signed, the terms of the previous contracts still apply.

~~The Company’s United Kingdom salaried and hourly employees are eligible to participate in Unite the Union ("UNITE") on an individual basis, but not under a collective bargaining agreement.~~(c) Indefinite term contract with periodic revisions every two years.

Note 10. Assets Held For Sale and Asset Restructuring Costs

2021 Appleton Mill Closure

On June 28, 2021, the Company's Board of Directors approved the permanent closure of the manufacturing facility in Appleton, Wisconsin (the “Appleton Mill”) used in the Technical Products segment. The closure of the facility was substantially complete as of September 30, 2021. In connection with the closure, the Company reduced the carrying value of these assets from the net book value of $43.0 million to an estimated salvage value, which resulted in a non-cash impairment loss of $32.4 million ($24.3 million, net of tax). The salvage value was determined using third-party appraisal estimates based on observable market inputs (Level 2). In addition, the Company recorded $5.0 million of other restructuring charges, including reserves for obsolescence of inventory and environmental exposure, severance costs and a curtailment loss on the pension obligations of the terminated workers. Further, the Company incurred a charge of $2.9 million relating to the loss of certain deferred income tax benefits.

During the third quarter of 2021, the Company initiated a process to market for sale the Appleton Mill ("disposal group"). The contemplated disposal transaction does not constitute a strategic shift in the business that will have a major effect on operations of the Company. The disposal group was measured at the lower of carrying value and fair value (a Level 2 measurement, based on observable market inputs), less costs to sell. As of March 31, 2022, the disposal group of assets of $10.5 million (consisting of property, plant and equipment) was separately reported as Assets held for sale in the Condensed Consolidated Balance Sheet. In addition, an estimated environmental liability of $0.5 million was reported separately as Liabilities of assets held for sale in the Condensed Consolidated Balance Sheet as of March 31, 2022. For the three months ended March 31, 2022, the Company incurred $0.6 million of asset restructuring costs related to the closure and sale of the facility.

Note 9.11. Business Segment Information

The Company’s reportable operating segments consist of Technical Products and Fine Paper and Packaging.

In January 2021, the Company realigned management of the publishing products component of the Technical Products segment to be part of the Fine Paper and Packaging segment. As a result, the Company recast the comparable 2020 information and presented the $9.9 million of net sales and $1.0 million of operating income for the three months ended March 31, 2020 formerly in the Technical Products segment as part of the Fine Paper and Packaging segment. The Company also recast the total assets by segment and presented the $21.0 million of total assets as of December 31, 2020 related to publishing products within the Fine Paper and Packaging segment.

~~F-13~~

~~Table of Contents~~

The Technical Products segment is an aggregation of the Company’s fiber-formed, coated and/or saturated specialized media that deliver high performance benefits to its international customers, which are similar in terms of economic characteristics, nature of products, processes, customer class and product distribution methods. The segment is an international producer of filtration media for transportation, water and other end uses; tape and abrasives backings products, durable label and other specialty substrates used for industrial solutions; and specialty coatings media used for digital image transfer, release liners and other applications.

~~During~~

F-14

Table of Contents

The increase in the ~~three months ended March 31, 2021, the Company further disaggregated the former performance materials business into industrial solutions and~~ specialty coatings ~~components, and recast~~component beginning in the ~~prior year period disclosure.~~second quarter of 2021 was due to the Itasa acquisition (see Note 4, "Acquisition"). The following table presents sales by product category for the Technical Products businesses:


		Three Months Ended March 31,				Three Months Ended March 31,
		2021		2020				2022		2021
Filtration	Filtration	52	%	45	%		Filtration	38	%	52	%
Industrial solutions	Industrial solutions	38	%	42	%		Industrial solutions	31	%	38	%
Specialty coatings	Specialty coatings	10	%	13	%		Specialty coatings	31	%	10	%
Total	Total	100	%	100	%		Total	100	%	100	%

The Fine Paper and Packaging segment is a leading supplier of premium printing and other high-end specialty papers and premium packaging, primarily in North America. During the three months ended March 31, 2021, the Company further disaggregated the former graphic imaging business into commercial and consumer components and recast the prior year disclosure to combine the consumer and packaging businesses based on the similarity of final customers and end markets they serve. The following table presents sales by product category for the Fine Paper and Packaging businesses:


		Three Months Ended March 31,				Three Months Ended March 31,
		2021		2020				2022		2021
Commercial	Commercial	55	%	58	%		Commercial	53	%	55	%
Consumer and packaging	Consumer and packaging	45	%	42	%		Consumer and packaging	47	%	45	%

Total	Total	100	%	100	%		Total	100	%	100	%

Each segment employs different technologies and marketing strategies. Disclosure of segment information is on the same basis that management uses internally for evaluating segment performance and allocating resources. Transactions between segments are eliminated in consolidation. The costs of shared services, and other administrative functions managed on a common basis, are allocated to the segments based on usage, where possible, or other factors based on the nature of the activity. General corporate expenses that do not directly support the operations of the business segments are shown as Unallocated corporate costs.

The following tables summarize the net sales, operating income (loss), and total assets for each of the Company’s business segments:


		Three Months Ended March 31,				Three Months Ended March 31,
		2021		2020				2022		2021
Net sales	Net sales						Net sales
Technical Products	Technical Products	$	145.2	$	132.3		Technical Products	$	185.6	$	145.2
Fine Paper and Packaging	Fine Paper and Packaging	81.8		101.3			Fine Paper and Packaging	99.2		81.8
Consolidated	Consolidated	$	227.0	$	233.6		Consolidated	$	284.8	$	227.0


		Three Months Ended March 31,				Three Months Ended March 31,
		2021 (a)		2020 (b)				2022 (a)		2021 (b)
Operating income
Operating income (loss)							Operating income (loss)
Technical Products	Technical Products	$	19.2	$	15.2		Technical Products	$	12.1	$	19.2
Fine Paper and Packaging	Fine Paper and Packaging	12.7		15.8			Fine Paper and Packaging	11.9		12.7
Unallocated corporate costs		(18.3)		(7.4)
Unallocated Corporate							Unallocated Corporate	(11.8)		(18.3)
Consolidated	Consolidated	$	13.6	$	23.6		Consolidated	$	12.2	$	13.6

(a) Operating income for the three months ended March 31, 2022 included (1) $4.9 million of due diligence and transaction costs related to the pending merger with SWM (see Note 12, "Merger Agreement"), (2) $0.6 million of asset restructuring costs related to the Appleton Mill closure (see Note 10, "Assets Held for Sale and Asset Restructuring Costs"); (3) $0.6 million of incremental and direct costs of responding to COVID-19 ($0.5 million in Unallocated Corporate and $0.1 million in Fine Paper and Packaging); and (4) $0.4 million of integration costs related to Itasa ($0.2 million in Technical Products and $0.2 million in Unallocated Corporate) (see Note 4, "Acquisition").

~~F-14~~F-15

Table of Contents

~~(a)~~(b) Operating income ~~(loss)~~ for the three months ended March 31, 2021 included (1) $12.0 million of acquisition costs for ~~ITASA~~Itasa (see Note ~~10)~~4, "Acquisition") within Unallocated corporate costs; (2) $0.5 million of incremental and direct costs of responding to COVID-19 ($0.1 million within Technical Products, $0.3 million within Fine Paper and Packaging, and $0.1 million within Unallocated corporate costs); and (3) $0.0 million of other restructuring and non-routine costs ($0.2 million within Technical Products and $(0.2) million within Fine Paper and Packaging). ~~Refer to Note 1, "Background and Basis of Presentation" for further discussion.~~

(b) Operating income for the three months ended March 31, 2020 included (1) $1.1 million of costs ($0.6 million within Technical Products and $0.5 million within Fine Paper and Packaging) related to a one-time special payment to its mill operators related to the COVID-19 pandemic; (2) $1.4 million of restructuring and other non-routine costs ($0.2 million within Technical Products, $0.9 million within Fine Paper and Packaging, and $0.3 million within Unallocated corporate costs); and (3) $1.0 million of transaction costs of a terminated acquisition attempt within Unallocated corporate costs.


		March 31, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Total Assets (a)	Total Assets (a)						Total Assets (a)
Technical Products	Technical Products	$	533.4	$	531.0		Technical Products	$	802.9	$	800.7
Fine Paper and Packaging	Fine Paper and Packaging	227.0		213.4			Fine Paper and Packaging	246.9		228.4
Corporate and other (b)	Corporate and other (b)	62.8		62.2			Corporate and other (b)	56.0		52.6
Consolidated	Consolidated	$	823.2	$	806.6		Consolidated	$	1,105.8	$	1,081.7

(a) Segment identifiable assets are those that are directly used in the segments operations.

(b) Corporate assets are primarily deferred income taxes, lease ROU assets and cash.

The following table represents a disaggregation of revenue from contracts as a percentage of total revenue with customers by location of the selling entities for the three months ended March 31, ~~2021~~2022 and ~~2020:~~2021:


		Three Months Ended March 31,				Three Months Ended March 31,
		2021		2020				2022		2021
United States		64	%	70	%
North America							North America	59	%	64	%
Germany	Germany	30	%	23	%		Germany	24	%	30	%
Rest of Europe		6	%	7	%
Spain							Spain	11	%	—	%
Rest of the Europe							Rest of the Europe	6	%	6	%
Total	Total	100	%	100	%		Total	100	%	100	%

Note ~~10. Subsequent Event~~12. Merger Agreement

On ~~April 6, 2021, the Company completed its previously announced acquisition (the “Acquisition”) of all of the outstanding capital stock of Global Release Liners, S.L.~~March 28, 2022, Neenah, Schweitzer-Mauduit International, Inc., a ~~Spanish limited company~~Delaware corporation (“~~ITASA”~~SWM”), ~~from Magnum Capital~~ and ~~other minority shareholders for approximately €205 million ($243 million) in cash, inclusive~~Samurai Warrior Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of ~~debt extinguishment~~SWM (“Merger Sub”), entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”).

Pursuant to the Merger Agreement, and subject to ~~customary closing adjustments. ITASA, through its subsidiaries, is~~the terms and conditions thereof, Merger Sub will merge with and into Neenah (the “Merger”), with Neenah surviving the Merger as a ~~leading global coater~~direct and ~~converter~~wholly-owned subsidiary of ~~release liners used~~SWM. Subject to the terms and conditions set forth in ~~hygiene, tapes, industrial, labels, composites and various other end markets. The Acquisition was funded with available cash-on-hand and~~ the ~~net proceeds~~Merger Agreement, at the effective time of the ~~Term Loan B discussed below. As~~Merger (the “Effective Time”), each share of ~~March 31, 2021,~~common stock of Neenah, par value $0.01 per share (“Neenah Common Stock”) then outstanding, other than certain excluded shares of Neenah Common Stock as described in the Company incurred $12.0 million of costs related to the Acquisition, including an unrealized loss of $6.2 million related to the foreign currency forward contracts negotiated to fund the purchase price in euros. See Note 1, ~~"Background and Basis of Presentation", for further discussion on these contracts.~~

~~The Company will account for the Acquisition in accordance with ASC 805,~~ ~~Business Combinations~~, which requires the assets acquired and the liabilities assumed to be measured at fair value at the date of the Acquisition. The Company has not included the unaudited pro forma information in this filing, as the Company is in process of finalizing the acquisition accounting. The ITASA businessMerger Agreement, will be ~~part of the Company's Technical Products segment.~~

~~In connection with the Acquisition, on April 6, 2021, the Company entered~~automatically converted into the ~~Term Loan Credit~~right to receive 1.358 shares of SWM common stock, par value $0.10 per share. Holders of Neenah Common Stock will receive cash in lieu of fractional shares. The Merger Agreement which provides a seven-year term loan B facility in the initial principal amount of $450 million, which replaces the 2020 Term Loan B. The Term Loan B is repayable in equal quarterly installments commencing on September 30, 2021 in an aggregate annual

~~F-15~~

~~Table of Contents~~

amount equal to 1% of the original principal amount of the Term Loan B (subject to certain reductions in connection with debt prepayments and debt buybacks). Cash proceeds of borrowings on the closing date under the Term Loan B were usedwas unanimously approved by the ~~Company to pay the cash consideration for the Acquisition, including the repayment~~Boards of ~~certain existing debt~~Directors of ~~ITASA,~~each of Neenah and ~~to pay fees and expenses in connection with the Acquisition, the Term Loan B and the amendment of the ABL Credit Agreement.~~ SWM.

The ~~Company will use any remaining proceeds of the Term Loan B for general corporate purposes of the Company and its subsidiaries.~~

~~Under the terms of the Term Loan Credit~~Merger Agreement borrowings under the Term Loan B will bear interest at a per annum rate equal to either (a) the reserve-adjusted LIBOR rate for interest periods of one, two or three months, plus an applicable rate of 3.00% per annum, or (b) the Alternate Base Rate, plus an applicable rate of 2.00% per annum. “Alternate Base Rate” will be equal to the greatest of (1) the prime rate as quoted from time to time in The Wall Street Journal or published by the Federal Reserve Board, (2) the overnight bank funding rate established by the Federal Reserve Bank of New York, plus 50 basis points, and (3) one-month reserve-adjusted LIBOR plus 100 basis points. The Alternate Base Rate is subject to a “floor” of 1.5%, and the adjusted LIBOR rate is subject to a “floor” of 0.5%. The applicable interest rate under the Term Loan B was 3.50% as of April 6, 2021, which represented a 150 basis point reduction in the interest rate compared to the 2020 Term Loan B.

~~Also on April 6, 2021, the Company amended the ABL Credit Agreement by entering into a Fourth Amendment to Fourth Amended and Restated Credit Agreement (the "Fourth Amendment"). The Fourth Amendment,~~also provides, among other things, ~~adds provisions (a) specifically permitting the consummation~~that effective as of the ~~Acquisition, (b) permitting~~Effective Time, Ms. Julie Schertell, the ~~incurrence~~current Chief Executive Officer of Neenah, will serve as the Chief Executive Officer of the ~~Term Loan B,~~combined company, and ~~(c) permitting certain indebtedness, liens and other transactions to facilitate consummation~~Mr. John Rogers will serve as non-executive Chairman of the ~~Acquisition~~Board of Directors of the combined company. In addition, from the Effective Time until the 2025 Annual Meeting of SWM stockholders, or December 31, 2025, if an Annual Meeting of SWM Stockholders is not held in 2025, the Board of Directors of the combined company will be composed of nine directors, of which five will be designated by SWM (including Mr. Rogers), each of whom must be independent, and four will be designated by Neenah (including Ms. Schertell).

The Merger Agreement provides the combined company will be headquartered in Alpharetta, Georgia. SWM will change the name and the ~~financing~~NYSE ticker symbol of ~~working capital for ITASA.~~the combined company to such new name and ticker symbol as mutually agreed upon by Neenah and SWM, which change may occur as of or after the Effective Time.

F-16

Table of Contents

The completion of the Merger is subject to regulatory approvals, the approval by the shareholders of each company and other customary conditions.

The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, filed as Exhibit 2.1 to the Neenah, Inc. Current Report on Form 8-K, filed March 28, 2022 and incorporated herein by reference.

F-17

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis presents the factors that had a material effect on our financial position as of March 31, ~~2021~~2022 and our results of operations for the three months ended March 31, ~~2021~~2022 and ~~2020.~~2021. You should read this discussion in conjunction with our consolidated financial statements and the notes to those consolidated financial statements included in our most recent Annual Report on Form 10-K. This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements. See "Forward-Looking Statements" for a discussion of the uncertainties, risks and assumptions associated with these statements.

Executive Summary

On April 6, 2021, we completed the acquisition of ITASA for approximately €205 million ($243 million) with available cash-on-hand and the net proceeds of the Term Loan B. ITASA is a leading global coater and converter of release liners used in hygiene, tapes, industrial, labels, composites and various other end markets.

For the three months ended March 31, ~~2021,~~2022, consolidated net sales of $284.8 million increased $57.8 million (25%) from $227.0 million ~~decreased $6.6 million (3%) from~~in the same prior year period. The ~~10%~~ increase included incremental net sales from the Itasa acquisition, selling price actions to recover input costs and higher volume in Technical Products revenue was more than offset by lower sales in our Fine Paper and Packaging business (down 19%) primarily due to ongoing effects of COVID-19. The impact from lower net selling prices wasboth segments. These increases were partially offset by ~~favorable~~adverse effects of currency ~~effects.~~movements and a lower value sales mix in the Technical Products business.

Consolidated operating income decreased ~~$10.0~~$1.4 million ~~(42%~~(10%) from the prior year period to ~~$13.6~~$12.2 million for the three months ended March 31, ~~2021. Lower income in 2021 resulted~~2022. The reduction was primarily ~~from $12.0 million of costs related~~due to the ~~acquisition~~impacts of ~~ITASA. Excluding adjusting items~~availability of ~~$12.5 million~~labor and ~~$3.5 million in 2021~~raw materials, which drove higher labor costs, reduced efficiency and ~~2020, respectively, adjusted operating income~~higher waste. In addition, distribution costs increased significantly as a result of $26.1 million decreased $1.0 million from $27.1 million in the prior year. The decrease was due to lower operating income in Fine Paper and Packaging that was not fully offset by higher operating income in Technical Products. See the reconciliation table on F-20 for further detail.market inflation.

Cash ~~provided by~~used in operating activities of ~~$20.7~~$(2.0) million for the three months ended March 31, ~~2021 was $6.5~~2022 compared to $20.7 million ~~higher than cash generated of $14.2 million~~provided in the prior year period. The ~~increase~~decrease resulted from ~~lower~~the increase in working capital ~~requirements that more than offset~~needs resulting from the growth in net sales, lower ~~earnings. Cash used for investing activities of $5.0 million was slightly~~cash earnings and higher ~~than the $4.9 million~~tax payments in ~~the prior year period.~~

Both of our business segments continue to operate as vital suppliers of goods and services and we continue to take steps to ensure the safety of our employees, including maintaining social distancing measures and providing remote working environments for administrative employees. During the first quarter 2021, we experienced a limited number of confirmed COVID-19 cases in our U.S. operations and quarantined those individuals and first level exposed employees in accordance with the U.S. Centers for Disease Control and Prevention (the "CDC") guidelines. However, such cases did not cause any significant disruption to operations, nor disruptions to our supply chain.2022.

Results of Operations and Related Information

In this section, we discuss and analyze our net sales, earnings before interest and taxes (which we refer to as "operating income") and other information relevant to an understanding of our results of operations for the three months ended March 31, ~~2021~~2022 and ~~2020.~~

~~F-17~~

~~Table of Contents~~

2021.

Analysis of Net Sales — Three Months Ended March 31, ~~2021~~2022 and ~~2020~~2021

The following table presents net sales by segment, expressed as a percentage of total net sales:


		Three Months Ended March 31,								Three Months Ended March 31,
		2021				2020					2022		2021
Net sales	Net sales											Net sales
Technical Products	Technical Products	$	145.2	64	%	$	132.3	57	%			Technical Products	$	185.6	65	%	$	145.2	64	%
Fine Paper and Packaging	Fine Paper and Packaging	81.8		36	%	101.3		43	%			Fine Paper and Packaging	99.2		35	%	81.8		36	%
Consolidated	Consolidated	$	227.0	100	%	$	233.6	100	%			Consolidated	$	284.8	100	%	$	227.0	100	%

F-18

Table of Contents

The following table presents our net sales by segment for the three months ended March 31, ~~2021~~2022 and ~~2020:~~2021:


		Three Months Ended March 31,						Change in Net Sales Compared to Prior Period												Three Months Ended March 31,						Change in Net Sales Compared to Prior Period
										Change Due To																		Change Due To
				2021			2020			Total Change			Volume			Net Price (a)			Currency			2022			2021			Total Change			Volume			Net Price (a)			Currency
Technical Products	Technical Products	$	145.2		$	132.3		$	12.9		$	10.3		$	(4.3)		$	6.9	Technical Products	$	185.6		$	145.2		$	40.4		$	32.7		$	14.0		$	(6.3)
Fine Paper and Packaging	Fine Paper and Packaging	81.8			101.3			(19.5)			(16.0)			(3.5)			—		Fine Paper and Packaging	99.2			81.8			17.4			6.0			11.4			—
Consolidated	Consolidated	$	227.0		$	233.6		$	(6.6)		$	(5.7)		$	(7.8)		$	6.9	Consolidated	$	284.8		$	227.0		$	57.8		$	38.7		$	25.4		$	(6.3)

(a) Includes changes in selling ~~price~~prices and product mix.

Consolidated net sales of ~~$227.0~~$284.8 million for the three months ended March 31, ~~2021 decreased $6.6~~2022 increased $57.8 million ~~(3%~~(25%) from the prior year period. The ~~10%~~ increase included incremental net sales from the Itasa acquisition, selling price actions to recover input costs and higher volume in both segments. These increases were offset by adverse effects of currency movements and a lower value sales mix in the Technical Products ~~revenue was more than offset by lower sales in our Fine Paper and Packaging business (down 19%) primarily due to ongoing~~business. Excluding the effects of ~~COVID-19. The impact from lower net selling prices was partially offset by favorable currency effects.While down versus prior year, first quarter~~the April 2021 Itasa acquisition and a facility closure, consolidated net sales increased ~~10%~~12% from the ~~fourth quarter of 2020.~~prior year period.

•Net sales in our ~~technical products business~~Technical Products segment increased ~~$12.9~~$40.4 million ~~(10%~~(28%) from the prior year period. The ~~revenue~~ increase was ~~primarily driven by growth in transportation~~attributable to net sales from the acquisition of Itasa and ~~industrial filtration sales, as well as media for face masks in Europe. The favorable currency effects~~ from ~~a stronger euro~~selling price actions to recover ongoing input cost impacts. These increases were partly offset by lost sales from the facility closure, a lower value product mix and adverse currency effects. Excluding the effects of the Itasa acquisition and the facility closure, net ~~selling prices in 2021. Net~~ sales ~~also continued to grow sequentially since the second quarter of 2020 and were 11% higher than the fourth quarter of 2020.~~increased 6%.

•Net sales in our ~~fine paper~~Fine Paper and ~~packaging business decreased $19.5~~Packaging segment increased $17.4 million ~~(19%~~(21%) from the prior year period. The ~~decline was primarily due~~improvement reflected selling price actions to ~~lower~~offset ongoing input cost increases and continued organic growth in volumes ~~resulting from COVID-19, with the largest impact~~ in commercial print products used for advertising and marketing. In addition, net selling prices were lower in 2021 due to a lower priced mix. Although down from prior year, net sales continued to grow sequentially since the second quarter of 2020 and were 8% higher than the fourth quarter of 2020.all product categories.

~~F-18~~

~~Table of Contents~~

Analysis of Operating Income — Three Months Ended March 31, ~~2021~~2022 and ~~2020~~2021

The following table sets forth line items from our Condensed Consolidated Statements of Operations as a percentage of net sales for the periods indicated and is intended to provide a perspective of trends in our historical results:


		Three Months Ended March 31,				Three Months Ended March 31,
		2021		2020				2022		2021
Net sales	Net sales	100.0	%	100.0	%		Net sales	100.0	%	100.0	%
Cost of products sold	Cost of products sold	78.1		76.9			Cost of products sold	83.0		78.1
Gross profit	Gross profit	21.9		23.1			Gross profit	17.0		21.9
Selling, general and administrative expenses	Selling, general and administrative expenses	10.7		11.4			Selling, general and administrative expenses	10.6		10.7
Acquisition-related costs (Note 4)							Acquisition-related costs (Note 4)	1.9		5.3
Asset restructuring costs (Note 10)							Asset restructuring costs (Note 10)	0.2		—

Acquisition costs		5.3		0.5
COVID-19 costs		0.2		0.4
COVID-19 costs (Note 1)							COVID-19 costs (Note 1)	0.2		0.2

Other restructuring and non-routine costs		—		0.6

Other (income) expense - net		(0.4)		0.1
Other income, net							Other income, net	(0.2)		(0.4)
Operating income	Operating income	6.0		10.1			Operating income	4.3		6.1
Interest expense - net		1.4		1.2
Interest expense, net							Interest expense, net	1.8		1.4
Income before income taxes	Income before income taxes	4.6		8.9			Income before income taxes	2.5		4.7
Provision for income taxes	Provision for income taxes	0.9		1.9			Provision for income taxes	0.5		1.0
Net income	Net income	3.7	%	7.0	%		Net income	2.0	%	3.7	%

F-19

Table of Contents

The following table presents our operating income by segment for the three months ended March 31, ~~2021~~2022 and ~~2020:~~2021:


								Change in Operating Income Compared to Prior Period																								Change in Operating Income Compared to Prior Period
		Three Months Ended March 31,									Change Due To															Three Months Ended March 31,									Change Due To
							Total						Net			Input															Total						Net			Input
				2021			2020			Change			Volume			Price (a)			Costs (b)			Currency			Other (c)			2022			2021			Change			Volume			Price (a)			Costs (b)			Currency			Other (c)
Technical Products	Technical Products	$	19.2		$	15.2		$	4.0		$	2.2		$	(4.4)		$	(0.5)		$	1.3		$	5.4	Technical Products	$	12.1		$	19.2		$	(7.1)		$	10.0		$	17.6		$	(20.0)		$	(0.6)		$	(14.1)
Fine Paper and Packaging	Fine Paper and Packaging	12.7			15.8			(3.1)			(5.1)			(2.0)			0.8			—			3.2		Fine Paper and Packaging	11.9			12.7			(0.8)			1.7			14.0			(8.8)			—			(7.7)
Unallocated corporate costs		(18.3)			(7.4)			(10.9)			—			—			—			—			(10.9)
Unallocated Corporate																									Unallocated Corporate	(11.8)			(18.3)			6.5			—			—			—			—			6.5
Consolidated	Consolidated	$	13.6		$	23.6		$	(10.0)		$	(2.9)		$	(6.4)		$	0.3		$	1.3		$	(2.3)	Consolidated	$	12.2		$	13.6		$	(1.4)		$	11.7		$	31.6		$	(28.8)		$	(0.6)		$	(15.3)

(a) Includes ~~changes in~~ selling price changes and a net favorable change in product mix.

(b) Includes ~~price~~cost changes for raw materials and energy.

(c) Includes the net ~~favorable~~unfavorable effects of other manufacturing costs, ~~over (under) absorption~~under-absorption of fixed costs, distribution and selling, general and administrative ("SG~~&A expenses.~~&A") expenses of $13.6 million in Technical Products and $7.7 million in Fine Paper and Packaging. In addition, these amounts ~~include~~included the net change in non-GAAP adjustments of ~~$0.5~~$(0.5) million, ~~$1.3~~$0.0 million, and ~~$(10.8)~~$6.5 million in Technical Products, Fine Paper and Packaging, and Unallocated corporate costs, respectively. See the reconciliation table on ~~F-20~~F-21 for further detail by segment and type of cost.

Consolidated operating income decreased ~~$10.0~~$1.4 million from the prior year period to ~~$13.6~~$12.2 million for the three months ended March 31, 2021. Lower income in 2021 resulted primarily from $12.0 million of costs related to the acquisition of ITASA, including third-party transaction fees and an unrealized loss on the foreign currency forward contracts negotiated to fund the purchase price.2022. Excluding adjusting items in both years, adjusted EBITDA of ~~$12.5 million and $3.5 million in 2021 and 2020, respectively, adjusted operating income of $26.1~~$30.3 million decreased ~~$1.0~~$5.4 million from ~~$27.1~~$35.7 million in the prior year. See the reconciliation table on F-21 for further detail of adjustments, and depreciation and amortization. The ~~decrease~~reduction was primarily due to ~~lower operating income in Fine Paper~~the impacts of availability of labor and ~~Packaging that was not fully offset by~~raw materials, which drove higher ~~operating income in Technical Products.~~labor costs, reduced efficiency and higher waste. In addition, distribution costs increased significantly as a result of market inflation.

•Operating income for our ~~technical products business increased $4.0~~Technical Products segment decreased $7.1 million from the prior year period to ~~$19.2 million, primarily as a result of lower manufacturing~~$12.1 million. The reduction was driven by labor and raw material availability challenges, reduced efficiency and waste. Despite contractual price adjustments realized, these input and distribution costs ~~increased volume, lower SG&A spending, favorable foreign currency, partly~~remain high and were not fully recovered. These factors more than offset ~~by net of lower selling prices.~~the significant benefit from the Itasa acquisition. Excluding ~~unfavorable~~ adjusting items ~~of $0.3 million in 2021 and $0.8 million in 2020~~ shown on the reconciliation table on ~~F-20,~~F-21, adjusted ~~operating income increased $3.5~~EBITDA decreased $4.7 million ~~(22%)~~ from ~~$16.0~~$24.9 million in the prior year period to ~~$19.5~~$20.2 million.

•Operating income for our ~~fine paper~~Fine Paper and ~~packaging business~~Packaging segment decreased ~~$3.1~~$0.8 million from the prior year period to ~~$12.7~~$11.9 million, primarily as a result of ~~lower sales~~higher labor and ~~production volume and less~~other manufacturing costs which more than offset favorable ~~sales mix. The~~input cost recoveries. In addition, current year results included the approximately $2.0 million impact of ~~lower volumes was partly offset by SG&A spending reductions~~costs and ~~modest benefits from lower input costs.~~lost sales related to the fire at our Brownville, NY facility in January. Excluding

~~F-19~~

~~Table of Contents~~

~~unfavorable~~ adjusting items ~~of $0.1 million in 2021 and $1.4 million in 2020~~ shown on the reconciliation table on ~~F-20,~~F-21, adjusted ~~operating income~~EBITDA of ~~$12.8~~$14.5 million in ~~2021~~2022 decreased ~~$4.4~~$0.8 million ~~(26%)~~ from ~~$17.2~~$15.3 million in the prior year.

•Unallocated corporate expenses of ~~$18.3~~$11.8 million ~~increased $10.9~~decreased $6.5 million from the prior year primarily due to costs of $12.0 million related to the ITASA acquisition, including a $6.2 million unrealized loss on the foreign currency forward contracts negotiated to fund the purchase price in euros.year. Excluding ~~unfavorable~~ adjustments ~~in 2021 and 2020 of $12.1 million and $1.3 million, respectively,~~ shown on the reconciliation table on ~~F-20,~~F-21, adjusted ~~unallocated corporate expenses~~EBITDA of ~~$6.2~~Unallocated Corporate was $(4.4) million ~~increased $0.1~~in 2022 and $(4.5) million ~~from prior year.~~

in 2021. The excluded costs in 2021 related to the Itasa acquisition and in 2022 primarily related to the pending merger with SWM.

F-20

Table of Contents

The following table sets forth our operating income (loss) by segment, adjusted for the effects of non-routine certain costs, for the periods indicated:


	Three Months Ended March 31,
	2022		2021
Technical Products
GAAP operating income	$	12.1	$	19.2
Asset restructuring costs	0.6		—
Acquisition-related costs	0.2		—
Other restructuring and non-routine costs	—		0.2
COVID-19 costs	—		0.1


Adjusted operating income	12.9		19.5
Depreciation and amortization of intangible assets and stock compensation	7.3		5.4
Adjusted EBITDA	20.2		24.9

Fine Paper and Packaging
GAAP operating income	11.9		12.7

Other restructuring and non-routine costs	—		(0.2)

COVID-19 costs	0.1		0.3
Adjusted operating income	12.0		12.8
Depreciation and amortization of intangible assets and stock compensation	2.5		2.5
Adjusted EBITDA	14.5		15.3

Unallocated Corporate Costs
GAAP operating loss	(11.8)		(18.3)
Acquisition-related costs	5.1		12.0

COVID-19 costs	0.5		0.1


Adjusted operating loss	(6.2)		(6.2)
Depreciation and amortization of intangible assets and stock compensation	1.8		1.7
Adjusted EBITDA	(4.4)		(4.5)

Consolidated
GAAP operating income	12.2		13.6
Acquisition-related costs	5.3		12.0
Asset restructuring costs	0.6		—

COVID-19 costs	0.6		0.5


Adjusted operating income	18.7		26.1
Depreciation and amortization of intangible assets and stock compensation	11.6		9.6
Adjusted EBITDA	$	30.3	$	35.7

Three Months Ended March 31,
2021 2020
Technical Products
GAAP Operating Income $ 19.2 $ 15.2
COVID-19 costs 0.1 0.6
Other restructuring and non-routine costs 0.2 0.2
Adjusted Operating Income 19.5 16.0
Fine Paper and Packaging
GAAP Operating Income 12.7 15.8
COVID-19 costs 0.3 0.5
Other restructuring and non-routine costs (0.2) 0.9
Adjusted Operating Income 12.8 17.2
Unallocated Corporate Costs
GAAP Operating Loss (18.3) (7.4)
Acquisition costs 12.0 1.0
COVID-19 costs 0.1 —
Other restructuring and non-routine costs — 0.3
Adjusted Operating Loss (6.2) (6.1)
Consolidated
GAAP Operating Income 13.6 23.6
Acquisition costs 12.0 1.0
COVID-19 costs 0.5 1.1
Other restructuring and non-routine costs — 1.4
Adjusted Operating Income $ 26.1 $ 27.1

In accordance with generally accepted accounting principles in the United States ("GAAP"), consolidated operating income ~~(loss)~~ includes the pre-tax effects of ~~acquisition~~asset restructuring costs, ~~COVID-19~~acquisition-related costs and ~~other restructuring and non-routine~~COVID-19 costs. We believe that by adjusting reported operating income to exclude the effects of such items, the resulting adjusted operating income is on a basis that reflects the results of our ongoing operations. In assessing COVID-19 impacts, we excluded only costs which were unusual, incremental and directly attributable to mitigating the effects of COVID-19 on our operations. We believe that providing adjusted operating results will help investors gain an additional perspective of underlying business trends and results. Adjusted operating income is not a recognized term under GAAP and should not be considered in isolation or as a substitute for operating income derived in accordance with GAAP. Other companies may use different methodologies for calculating their non-GAAP financial measures and, accordingly, our non-GAAP financial measures may not be comparable to their measures.

F-21

Table of Contents

Additional Statement of Operations Commentary:

•SG&A expense of ~~$24.3~~$30.3 million for the three months ended March 31, ~~2021~~2022 was ~~$2.3~~$6.0 million ~~lower~~higher than SG&A expense of ~~$26.6~~$24.3 million in the prior year period. ~~Costs in~~The majority of the ~~first quarter of 2021 were lower~~increase was due to additional SG&A of the significant actions taken to manage spending and reduce costs during 2020 in areas such as marketing, travel and payroll. Costs in the first quarter of 2020 also included a higher provision for uncollectible accounts receivable and legal expenses.Itasa business.

•For the three months ended March 31, ~~2021,~~2022, net interest expense of ~~$3.1~~$5.0 million was higher than the ~~$2.9~~$3.1 million in the first quarter of ~~2020,~~2021 due to the higher borrowing under the upsized Term Loan B and amortization ~~expense for~~of the associated deferred financing ~~costs on the Term Loan B.~~costs.

~~F-21~~

~~Table of Contents~~

•Historically, our effective income tax rate has differed from the U.S. statutory tax rate primarily due to the proportion of pre-tax income in jurisdictions with marginal tax rates that differ from the U.S. statutory tax rate, research and development and other tax credits and excess tax benefits from stock compensation. For the three months ended March 31, ~~2021~~2022 and ~~2020,~~2021, we recorded an income tax ~~expense~~provision of ~~$2.2~~$1.5 million and ~~$4.3~~$2.2 million, respectively. The effective income tax rate was 21% ~~for~~in both ~~the three months ended March 31, 2021 and March 31, 2020.~~periods.

Liquidity and Capital Resources

We believe that our financial position and liquidity remain strong, considering as of March 31, ~~2021,~~2022, we had:

•no near-term debt maturities, as the Global Revolving Credit Facility matures in December 2023 and the ~~2020~~ Term Loan B matures in ~~June 2027;~~April 2028;

•significant remaining availability of ~~$155.7~~$137.8 million on our Global Revolving Credit Facility, with no$23.3 million outstanding borrowings; and

•$~~41.0~~25.2 million of cash and cash equivalents on ~~hand;~~

•and, on April 6, 2021, in connection with the acquisition of ITASA, we successfully completed the upsizing of our Term Loan B facility from $200 million to $450 million, maturing in April 2028. See Note 10, "Subsequent Events" of Notes to Condensed Consolidated Financial Statements, for further discussion.hand.


		Three Months Ended March 31,					Three Months Ended March 31,
		2021		2020			2022		2021
Net cash flow provided by (used in):	Net cash flow provided by (used in):					Net cash flow provided by (used in):
Operating activities	Operating activities	$	20.7	$	14.2	Operating activities	$	(2.0)	$	20.7

Investing activities:	Investing activities:					Investing activities:
Capital expenditures	Capital expenditures	(4.8)		(4.8)		Capital expenditures	(8.3)		(4.8)

Other investing activities	Other investing activities	(0.2)		(0.1)		Other investing activities	(0.1)		(0.2)
Total	Total	(5.0)		(4.9)		Total	(8.4)		(5.0)

Financing activities:	Financing activities:					Financing activities:
Net borrowings (repayments) of long-term debt	Net borrowings (repayments) of long-term debt	(1.2)		71.7		Net borrowings (repayments) of long-term debt	20.6		(1.2)
Cash dividends paid	Cash dividends paid	(8.0)		(8.0)		Cash dividends paid	(8.0)		(8.0)
Shares purchased	Shares purchased	(0.4)		(3.8)		Shares purchased	(0.2)		(0.4)
Other financing activities	Other financing activities	(1.4)		(0.5)		Other financing activities	(0.2)		(1.4)
Total	Total	(11.0)		59.4		Total	12.2		(11.0)
Effect of exchange rate changes on cash and cash equivalents	Effect of exchange rate changes on cash and cash equivalents	(0.8)		(0.2)		Effect of exchange rate changes on cash and cash equivalents	(0.5)		(0.8)
Net increase in cash and cash equivalents and restricted cash	Net increase in cash and cash equivalents and restricted cash	$	3.9	$	68.5	Net increase in cash and cash equivalents and restricted cash	$	1.3	$	3.9

Operating Cash Flow Commentary

•Cash ~~provided by~~used in operating activities of ~~$20.7~~$(2.0) million for the three months ended March 31, ~~2021~~2022 was ~~$6.5~~$22.7 million ~~higher~~lower than cash provided by operating activities of ~~$14.2~~$20.7 million in the prior year period. The increase resulted from lower working capital requirements that more than offset lower earnings. The significant increases in accounts receivable, accounts payable and accrued expenses during the three months ended March 31, 2021decrease resulted from the ~~sequential~~increase in working capital needs resulting from the growth in ~~business activity~~net sales, lower cash earnings and ~~unpaid ITASA acquisition costs.~~higher tax payments in 2022.

F-22

Table of Contents

Investing Commentary:

•For the three months ended March 31, 2022, and 2021, ~~and 2020, cash used by investing activities was $5.0~~capital expenditures were $8.3 million and ~~$4.9~~$4.8 million, respectively. We expect aggregate annual capital expenditures to return to a range of approximately 24 to 45 percent of net sales. We believe that this level of capital spending can be funded from cash provided from operating activities and allows us to maintain the efficiency and cost effectiveness of our assets while also investing in expanded capabilities to successfully pursue strategic initiatives and deliver attractive returns.

Financing Commentary:

•For the three months ended March 31, ~~2021,~~2022, cash and cash equivalents increased ~~$3.9~~to $25.2 million ~~to $41.0 million at March 31, 2021~~ from ~~$37.1~~$23.9 million at December 31, ~~2020.~~2021. As of March 31, ~~2021,~~2022, our cash balance consisted of ~~$14.7~~$4.3 million in the U.S. and ~~$26.3~~$20.9 million held at entities outside of the U.S. As of March 31, ~~2021,~~2022, there were no restrictions regarding the repatriation of our non-U.S. cash.

•For the three months ended March 31, ~~2021,~~2022, cash ~~used~~provided in financing activities was ~~$11.0~~$12.2 million. Cash flows related to financing activities ~~consists primarily~~consisted of net ~~borrowings/repayments~~borrowings of long-term debt, dividends paid and share repurchases. During the three months ended March 31, 2021, we made net repayments of $1.2 million as compared to net borrowings of $71.7 million during the prior year period, when we increased cash on hand through borrowings against our Global Revolving Credit Facilities near quarter-end as a precautionary measure to protect against any potential disruption in the banking system that would adversely impact our short-term ability to access cash as a result of COVID-19 effects.

•Availability under our Global Revolving Credit Facility varies over time depending on the value of our inventory, receivables and various capital assets. As of March 31, ~~2021,~~2022, we had no$23.3 million of outstanding borrowings under our Global Revolving Credit Facility and ~~$155.7~~$137.8 million of available credit (based on exchange rates at March 31, ~~2021)~~2022).

•As of March 31, ~~2021,~~2022, we had required debt principal payments through March 31, ~~2022~~2023 of ~~$2.8~~$4.5 million for ~~principal payments on~~ the ~~two German loan agreements and $2.0 million for the 2020~~ Term Loan B payable in equal quarterly installments.

•On April 6, 2021, in connection with the acquisition of ITASA, we completed the upsizing of our Term Loan facility from $200 million to $450 million, maturing in April 2028. See Note 10, "Subsequent Events" of Notes to Condensed Consolidated Financial Statements, for further discussion.

Transactions With Shareholders

•For ~~each of~~ the three months ended March 31, ~~2021~~2022 and ~~2020,~~2021, we paid cash dividends of $8.0 million and $8.0 million ($~~0.47~~0.475 and $0.47 per common share)., respectively.

•In November 2020, the Board of Directors authorized an evergreen program for the repurchase of up to $25 million of outstanding Common Stock. This plan does not require us to purchase any specific number of shares and may be suspended or discontinued at any time. ~~We did not purchase any shares during the first quarter of 2021.~~ For the three months ended March 31, ~~2020, we~~2022 and 2021, no shares were repurchased ~~59,577 shares of Common Stock at a cost of $3.6 million.~~under this program. For further details on our Stock Purchase Plans, refer to Note 7,8, "Stockholders' Equity" of Notes to Condensed Consolidated Financial Statements.

Other Items:

•As of March 31, ~~2021,~~2022, we had ~~$69.4~~$65.7 million of state NOLs. Our state NOLs may be used to offset ~~$4.3~~$4.0 million in state income taxes. If not used, substantially all of the state NOLs will expire in various amounts between ~~2021~~2022 and ~~2040.~~2041. In addition, as of March 31, ~~2021,~~2022, we had ~~$27.6~~$27.9 million of U.S. federal and ~~$7.3~~$7.7 million of U.S. state research and development tax credits ("R&D Credits") which, if not used, will expire between ~~2029~~2030 and ~~2041~~2042 for the U.S. federal R&D Credits and between ~~2021~~2022 and ~~2036~~2037 for the state R&D Credits.

Management believes that our ability to generate cash from operations and our borrowing capacity are adequate to fund working capital, capital spending and other cash needs for the next 12 months. Our ability to generate adequate cash from operations beyond ~~2021~~2022 will depend on, among other things, our ability to successfully implement our business strategies, control costs in line with market conditions, and manage the impact of changes in input prices and the impact and duration of COVID-19. We can give no assurance we will be able to successfully implement these items.

F-23

Table of Contents

Critical Accounting Policies and Use of Estimates

The preparation of financial statements in conformity with GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. We believe that the estimates, assumptions and judgments described in "Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Use of Estimates" of our most recent Annual Report on Form 10-K have the greatest potential impact on our financial statements, so we consider these to be our critical accounting policies. The critical accounting policies used in the preparation of the consolidated financial statements are those that are important both to the presentation of financial condition and results of operations and require significant judgments with regard to estimates used. These critical judgments relate to the timing of recognizing sales revenue, the recoverability of deferred income tax assets, pension benefits, ~~and~~ future cash flows associated with impairment testing of long-lived ~~assets.~~assets and acquisition accounting which requires companies to record assets acquired and liabilities assumed at their respective fair value at the date of acquisition. Actual results could differ from these fair value measurements and estimates and changes in these estimates are recorded when known. We believe that the consistent application of these policies enables us to provide readers of our financial statements with useful and reliable information about our operating results and financial condition. There have been no significant changes in these policies or the estimates used in the application of the policies since December 31, ~~2020.~~2021.

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this Quarterly Report on Form 10-Q may constitute "forward-looking" statements as defined under federal securities laws. Statements contained in this quarterly report that are not historical facts may be forward-looking statements within the meaning under federal securities laws and we caution investors that any forward-looking statements we make are not guarantees or indicative of future performance. These forward-looking statements rely on a number of assumptions concerning future events and are subject to risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to materially differ from such statements. Such risks, uncertainties and other factors include, but are not necessarily limited to, those set forth under the captions "Cautionary Note Regarding Forward-Looking Statements" and/or "Risk Factors" of our latest Form 10-K filed with the SEC as periodically updated by subsequently filed Form 10-Qs (these securities filings can be located on our website at www.neenah.com). Unless specifically required by law, we assume no obligation to update or revise these forward-looking statements to reflect new events or circumstances. These cautionary statements are being made pursuant to federal securities laws with the intention of obtaining the benefits of the "safe harbor" provisions of such laws.

You can identify forward-looking statements as those that are not historical in nature, particularly those that use terminology such as "may," "will," "should," "expect," "anticipate," "contemplate," "estimate," "believe," "plan," "project," "predict," "potential" or "continue," or the negative of these, or similar terms. In evaluating these forward-looking statements, you should consider the following factors, as well as others contained in our public filings from time to time, which may cause our actual results to differ materially from any forward-looking statement:

• changes in market demand for our products due to global economic and political ~~conditions;~~conditions or our inability to execute product innovation strategies;

•the impact of competition, both domestic and international, changes in industry production capacity, including the construction of new mills or new machines, the closing of mills and incremental changes due to capital expenditures or productivity increases;

•the loss of current customers or the inability to obtain new customers;

•increases in commodity prices (particularly for pulp, energy and latex);

•our ability to control costs, including transportation, and implement measures designed to enhance operating efficiencies;

•the availability of raw materials and ~~energy;~~energy and other supply chain interruptions;

•the impact of cybersecurity risks related to breaches of security pertaining to sensitive Company, customer or vendor information, as well as breaches in the technology that manages operations and other business processes;

•loss and replacement of key personnel;

•our ability to identify attractive acquisition targets and to successfully integrate acquired businesses into our existing operations;

F-24

Table of Contents

•changes in asset valuations, including write-downs of assets including property, plant and equipment; inventory, accounts receivable, deferred tax assets or other assets for impairment or other reasons;

•the enactment of adverse federal, state or foreign tax or other legislation or changes in government policy or regulation;

•the impact of increased trade protectionism and tariffs on our business, results of operations and financial condition;

•unanticipated expenditures related to the cost of compliance with environmental and other governmental regulations;

•fluctuations in foreign currency exchange rates (in particular, changes in the U.S. dollar/Euro currency exchange rates) and interest rates on long-term debt;

•increases in the funding requirements for our pension and postretirement liabilities;

~~F-24~~

~~Table of Contents~~

•~~our ability to identify attractive acquisition targets and to successfully integrate acquired businesses into our existing operations;~~

•~~loss of key personnel;~~

•strikes, labor stoppages and changes in our collective bargaining agreements and relations with our employees and unions;

•capital and credit market volatility and fluctuations in global equity and fixed-income markets;

•our existing and future indebtedness;

•our NOLs may not be available to offset our tax liabilities and other tax planning strategies may not be effective; and

•other risks that are detailed from time to time in reports we file with the SEC.

Any subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth or referred to above, as well as the risk factors contained in our most recent Annual Report on Form 10-K. Except as required by law, we disclaim any obligation to update such statements or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future events or developments.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes to the disclosure on this matter made in our Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management in a timely manner.

As of March 31, ~~2021,~~2022, an evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on that evaluation, our management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of March 31, ~~2021.~~2022.

Internal Control over Financial Reporting

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated whether any change in our internal control over financial reporting occurred during the three months ended March 31, ~~2021.~~2022. Based on that evaluation, we have concluded that there has been no change in our internal control over financial reporting during the three months ended March 31, ~~2021~~2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

F-25

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

See Note 8,9, "Contingencies and Legal Matters" of Notes to Condensed Consolidated Financial Statements.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A, "Risk Factors" of our most recent Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities:

The following table contains information about our purchases of our equity securities for the three months ended March 31, ~~2021:~~2022:


							Issuer Purchases of Equity Securities
			Shares Purchased as Part of Publicly Announced Plans or Programs in 2021 (b)						Shares Purchased as Part of Publicly Announced Plans or Programs (b)
Month	Month	Total Number of Shares Purchased (a)	Average Price Paid Per Share	Total Number of Shares Purchased	Approximate Dollar Value of Shares that May Yet Be Purchased	Month	Total Number of Shares Purchased (a)	Average Price Paid Per Share	Total Number of Shares Purchased	Approximate Dollar Value of Shares that May Yet Be Purchased
January	January	5,213	$—	—	$25,000,000	January	245	$46.76	—	$20,000,017
February	February	1,668	$—	—	$25,000,000	February	4,426	$46.30	—	$20,000,017
March	March	—	$—	—	$25,000,000	March	—	$—	—	$20,000,017

(a) Transactions include the purchase of vested restricted shares from employees to satisfy minimum tax withholding requirements upon vesting of stock-based awards. See Note 78, "Stockholders' Equity" of Notes to Condensed Consolidated Financial ~~Statements, "Stockholders' Equity."~~Statements.

(b) In November 2020, our Board of Directors authorized a program for the purchase of up to $25 million of outstanding common stock effective January 1, 2021. The program does not require the Company to purchase any specific number of shares and may be suspended or discontinued at any time. For the three months ended March 31, ~~2021,~~2022, there were no ~~purchases~~shares repurchased under this program.

F-26

Item 6. Exhibits


Exhibit Number						Exhibit
~~10.1~~2.1						~~Term Loan Credit~~ Agreement and Plan of Merger, dated ~~April 6, 2021,~~March 28, 2022, by and among Neenah, Inc, Schweitzer-Mauduit International, Inc., ~~certain of its subsidiaries,~~and Samurai Warrior Merger Sub, Inc. (filed as Exhibit 2.1 to the ~~lenders listed therein~~Neenah, Inc. Current Report on Form 8-K, filed March 28, 2022 and ~~JPMorgan Chase Bank, N.A., as agent for the Lenders (filed herewith).~~incorporated herein by reference)

~~10.2~~3.1						~~Fourth Amendment, dated April 6, 2021, to the Fourth~~Third Amended and Restated ~~Credit Agreement dated December 10, 2018~~Bylaws of Neenah, Inc. (filed as Exhibit 3.1 to the Neenah, Inc. Current Report on Form 8-K filed March 28, 2022 and incorporated herein by ~~and among Neenah, Inc., certain of its subsidiaries, the lenders listed therein and JPMorgan Chase Bank, N.A., as agent for the Lenders (filed herewith).~~reference)

31.1						Certification of the CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2						Certification of the CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1						Certification of CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2						Certification of CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS						XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH						Inline XBRL Taxonomy Extension Schema Document (filed herewith).

101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith).

101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document (filed herewith).

101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document (filed herewith).

101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith).

F-27

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		~~NEENAH, INC.~~Neenah, Inc.

	By:	/s/ Julie A. Schertell
		Julie A. Schertell
		President, Chief Executive Officer and Director (Principal Executive Officer)

		/s/ Paul F. DeSantis
		Paul F. DeSantis
		Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)

		/s/ ~~Larry N. Brownlee~~Kimberly A. DeBrock
		~~Larry N. Brownlee~~Kimberly A. DeBrock
		Vice President, Controller (Principal Accounting Officer)


May ~~6, 2021~~4, 2022


	March 31, 2021		December 31, 2020
2020 Term Loan B (variable rates) due June 2027	$	198.5	$	199.0
Global Revolving Credit Facility (variable rates) due December 2023	0		0
German loan agreement (2.45% fixed rate) due in quarterly installments ending September 2022	2.0		2.4
German loan agreement (1.45% fixed rate) due in quarterly installments ending September 2022	2.1		2.6
Debt discounts and deferred financing costs	(10.6)		(9.6)
Total debt	192.0		194.4
Less: Debt payable within one year	4.8		4.9
Long-term debt	$	187.2	$	189.5